<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://jvi.asm.org/content/83/2/1093.full">
<meta name="wpd_url" content="http://jvi.asm.org/content/83/2/1093.full">
<meta name="wpd_date" content="2013-04-11T13:47Z">
<script async="" src="cb=gapi.loaded_0"></script>
      
      <title>Human Immunodeficiency Virus Type 1 Nef Incorporation into Virions Does Not Increase Infectivity </title>
      <meta name="googlebot" content="NOODP">
      <meta name="googlebot" content="NOODP">
      <meta name="HW.ad-path" content="/cgi/content/full/83/2/1093">
      <meta content="/jvi/83/2/1093.atom" name="HW.identifier">
      <meta name="DC.Format" content="text/html">
      <meta name="DC.Language" content="en">
      <meta content="Human Immunodeficiency Virus Type 1 Nef Incorporation into Virions Does Not Increase Infectivity" name="DC.Title">
      <meta content="10.1128/JVI.01633-08" name="DC.Identifier">
      <meta content="2009-01-15" name="DC.Date">
      <meta content="American Society for Microbiology" name="DC.Publisher">
      <meta content="Nadine Laguette" name="DC.Contributor">
      <meta content="Serge Benichou" name="DC.Contributor">
      <meta content="Stéphane Basmaciogullari" name="DC.Contributor">
      <meta content="Journal of Virology" name="citation_journal_title">
      <meta content="J. Virol." name="citation_journal_abbrev">
      <meta content="0022-538X" name="citation_issn">
      <meta content="1098-5514" name="citation_issn">
      <meta name="citation_author" content="Nadine Laguette">
      <meta name="citation_author" content="Serge Benichou">
      <meta name="citation_author" content="Stéphane Basmaciogullari">
      <meta content="Human Immunodeficiency Virus Type 1 Nef Incorporation into Virions Does Not Increase Infectivity" name="citation_title">
      <meta content="01/15/2009" name="citation_date">
      <meta content="83" name="citation_volume">
      <meta content="2" name="citation_issue">
      <meta content="1093" name="citation_firstpage">
      <meta content="1104" name="citation_lastpage">
      <meta content="83/2/1093" name="citation_id">
      <meta content="jvi;83/2/1093" name="citation_mjid">
      <meta content="10.1128/JVI.01633-08" name="citation_doi">
      <meta content="http://jvi.asm.org/content/83/2/1093.abstract" name="citation_abstract_html_url">
      <meta content="http://jvi.asm.org/content/83/2/1093.full" name="citation_fulltext_html_url">
      <meta content="http://jvi.asm.org/content/83/2/1093.full.pdf" name="citation_pdf_url">
      <meta content="http://jvi.asm.org/content/83/2/1093" name="citation_public_url">
      <meta content="18987145" name="citation_pmid">
      <meta name="citation_section" content="VIRUS-CELL INTERACTIONS">
      <meta name="robots" content="noarchive,nofollow">
      <meta name="googlebot" content="noarchive">
      <link href="http://jvi.asm.org/content/83/2/1083.short" rel="prev">
      <link href="http://jvi.asm.org/content/83/2/1105.short" rel="next">
      
      
      
      
      
      
      
      
      
      <script type="text/javascript" id="session-d378335822e1">var callbackToken='499BEBD212D89C1';</script><script type="text/javascript" src="jquery-min.js"></script><script type="text/javascript" src="hw-shared.js"></script><script type="text/javascript" src="hw-design1.js"></script><script type="text/javascript" src="hw-sheridanpod.js"></script><script type="text/javascript" src="hw-publisher-global.js"></script><script type="text/javascript" src="hw-content.js"></script><script type="text/javascript" src="AccessCheckLib.js"></script><script type="text/javascript" src="executeAccessCheck.js"></script><script type="text/javascript" src="jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="jquery.easing-1.3.pack.js"></script><script type="text/javascript" src="jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="content.jquery.addVariantLink.js"></script><script type="text/javascript" src="hw-col-expand.js"></script><script type="text/javascript" src="hw-publisher-content.js"></script><script type="text/javascript">

	                
                
        
                   var OAS_sitepage = 'jvi.asm.org';
                
    
           
	        </script><script type="text/javascript" src="ads-realmedia.js"></script>
<link rel="stylesheet" type="text/css" href="1093.css" media="all">
</head>
<body>
      <div id="dic_bubble" class="selection_bubble fontSize13 noSelect" style="z-index: 9999; border: 1px solid rgb(74, 174, 222);"></div><div class="hw-gen-page pagetype-content" id="pageid-content" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle">
         <div id="header">
            
            <h1><a href="http://www.asm.org/" id="society-link"><span>American Society for Microbiology</span></a><a id="logo" href="http://jvi.asm.org/"><span>Journal of Virology</span></a></h1>
            
            <p id="skip-link">
               <a href="#content-block">Skip to main page content</a>
               
            </p>
            
            <ul class="button-list header-buttons">
               <li class="first"><a href="http://jvi.asm.org/" title="Home"><span>Home</span></a></li>
               <li><a href="http://jvi.asm.org/content/current" title="Current Issue"><span>Current Issue</span></a></li>
               <li><a href="http://jvi.asm.org/content/by/year" title="Archive"><span>Archive</span></a></li>
               <li><a href="http://journals.asm.org/cgi/alerts/etoc" title="Alerts"><span>Alerts</span></a></li>
               <li><a href="http://www.asm.org/about-asm" title="About ASM"><span>About ASM</span></a></li>
               <li><a href="http://jvi.asm.org/site/misc/contact.xhtml" title="Contact us"><span>Contact us</span></a></li>
               <li><a href="http://jvi.asm.org/cgi/feedback" title="Tech Support"><span>Tech Support</span></a></li>
               <li class="last"><a href="http://journals.asm.org/" title="Journals."><span>Journals.
                        <span xmlns="" class="red">ASM</span>.org</span></a></li>
            </ul>
            
            
            <div class="header-qs">
               
               <form class="searchbox" action="http://jvi.asm.org/search" method="get">
                  <div>
                     <label for="header-qs-input" id="header-qs-search-label">keywords</label>
                     <input style="color: rgb(160, 160, 160);" value="keywords" title="keywords" name="fulltext" id="header-qs-input" type="text"><input name="submit" value="yes" type="hidden"><a href="#" id="hdr-qs-search-a"><label for="header-qs-search" id="header-qs-search-label">GO</label></a><input value="GO" alt="Link: Go" id="header-qs-search-go" src="btn-go.gif" type="image">
                     
                  </div>
                  <div class="adv-search-link"><a href="http://jvi.asm.org/search">Advanced »</a></div>
               </form>    
               
            </div>
            
            <div class="header-ac-elements">
               
               <div class="inst-branding">
                  
               </div>
               
               <div id="authstring">
                  
                  
               </div> 
               
               
               <div id="hdr-login">
                  
                  <form action="http://jvi.asm.org/login" method="post">
                     <div>
                        <label for="hdr-login-username" id="hdr-login-username-label">User Name</label>
                        <input style="color: rgb(160, 160, 160);" name="username" id="hdr-login-username" type="text">
                        <label for="hdr-login-password" id="hdr-login-password-label">Password</label>
                        <input style="color: rgb(160, 160, 160);" name="code" id="hdr-login-password" type="password">
                        <a href="#" id="hdr-login-signin-label-a"><label for="hdr-login-signin" id="hdr-login-signin-label">

                           Sign In
                           </label></a>
                        <input style="color: rgb(160, 160, 160);" value="http://jvi.asm.org/content/83/2/1093.full" name="uri" type="hidden">
                        <input style="color: rgb(160, 160, 160);" alt="sign in" value="
                           Sign In
                           " id="hdr-login-signin" src="login.gif" type="image">
                        
                     </div>
                  </form>
                  
               </div>
               
            </div>
            
            <div class="banner-ads">
               
               <ul>
                  <li class="position-1 no-ad hdr_left"><span>  </span></li>
               </ul>
               
            </div>
            
            <div class="bar">
               
               <div class="bar-inner"></div>
               
            </div>
            
         </div>
         <div style="height: auto;" id="content-block"><div id="content-option-box" title="Expand this column"><ul><li id="content-toggle"><a href="#"><span class="descr">Expand</span><span>+</span></a></li></ul></div><div id="print-slug" class="print-only"><span class="jnl-title">Journal of Virology</span><span class="jnl-url">jvi.asm.org</span><div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              
                              		<span class="slug-metadata-note ahead-of-print">

                                 
                                 Published ahead of print
                                 
                                 <span class="slug-ahead-of-print-date">5 November 2008</span>,
                                 doi:
                                 <span class="slug-doi">10.1128/​JVI.01633-08
                                    </span>
                                 </span>
                              
                              <cite>
                                 	    <abbr title="Journal of Virology" class="slug-jnl-abbrev">

                                    J. Virol.</abbr><span class="slug-pub-date" itemprop="datePublished">

                                    	    January 2009 
                                    </span>
                                 	    <span class="slug-vol">

                                    vol. 83 
                                    </span><span class="slug-issue">

                                    no. 2 
                                    </span><span class="slug-pages">

                                    1093-1104
                                    </span>
                                 </cite>
                              
                           </div>
                        </li>
                     </ol>
                  </div></div>
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Human Immunodeficiency Virus Type 1 Nef Incorporation into Virions Does Not Increase Infectivity <a id="xref-fn-1-1" class="xref-fn" href="#fn-1">▿</a></h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://jvi.asm.org/search?author1=Nadine+Laguette&amp;sortspec=date&amp;submit=Submit">Nadine Laguette</a></span><a id="xref-aff-1-1" class="xref-aff" href="#aff-1">1</a><span class="xref-sep">,</span><a id="xref-aff-2-1" class="xref-aff" href="#aff-2">2</a>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://jvi.asm.org/search?author1=Serge+Benichou&amp;sortspec=date&amp;submit=Submit">Serge Benichou</a></span><a id="xref-aff-1-2" class="xref-aff" href="#aff-1">1</a><span class="xref-sep">,</span><a id="xref-aff-2-2" class="xref-aff" href="#aff-2">2</a><span class="xref-sep">,</span><a id="xref-corresp-1-1" class="xref-corresp" href="#corresp-1">*</a> and 
                     </li>
                     <li class="last" id="contrib-3"><span class="name"><a class="name-search" href="http://jvi.asm.org/search?author1=St%C3%A9phane+Basmaciogullari&amp;sortspec=date&amp;submit=Submit">Stéphane Basmaciogullari</a></span><a id="xref-aff-1-3" class="xref-aff" href="#aff-1">1</a><span class="xref-sep">,</span><a id="xref-aff-2-3" class="xref-aff" href="#aff-2">2</a><span class="xref-sep">,</span><a id="xref-corresp-1-2" class="xref-corresp" href="#corresp-1">*</a></li>
                  </ol><p class="affiliation-list-reveal"><a href="#" class="view-more">+</a> Author Affiliations</p>
                  <ol class="affiliation-list hideaffil">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address><sup>1</sup>Institut Cochin, CNRS UMR8104, Université Paris Descartes, Paris, France
                        </address>
                     </li>
                     <li class="aff"><a id="aff-2" name="aff-2"></a><address><sup>2</sup>INSERM U567, Paris, France
                        </address>
                     </li>
                  </ol>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder">&nbsp;</div><a href="#sec-1" title="MATERIALS AND METHODS" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>ABSTRACT</h2>
                  
                  <p id="p-1">The viral protein Nef contributes to the optimal infectivity of human and simian immunodeficiency viruses. The requirement
                     for Nef during viral biogenesis particles suggests that Nef might play a role in this process. Alternatively, because Nef
                     is incorporated into viruses, it might play a role when progeny virions reach target cells. We challenged these hypotheses
                     by manipulating the amounts of Nef incorporated in viruses while keeping its expression level constant in producer cells.
                     This was achieved by forcing the incorporation of Nef into viral particles by fusing a Vpr sequence to the C-terminal end
                     of Nef. A cleavage site for the viral protease was introduced between Nef and Vpr to allow the release of Nef fragments from
                     the fusion protein during virus maturation. We show that the resulting Nef-CS-Vpr fusion partially retains the ability of
                     Nef to downregulate cell surface CD4 and that high amounts of Nef-CS-Vpr are incorporated into viral particles compared with
                     what is seen for wild-type Nef. The fusion protein is processed during virion maturation and releases Nef fragments similar
                     to those found in viruses produced in the presence of wild-type Nef. Unlike viruses produced in the presence of wild-type
                     Nef, viruses produced in the presence of Nef-CS-Vpr do not have an increase in infectivity and are as poorly infectious as
                     viruses produced in the absence of Nef. These findings demonstrate that the presence of Nef in viral particles is not sufficient
                     to increase human immunodeficiency virus type 1 infectivity and suggest that Nef plays a role during the biogenesis of viral
                     particles.
                  </p>
                  
               </div>
               <div class="emptySection"></div><p id="p-2">In addition to the structural proteins common to all retroviruses, the genome of primate lentiviruses encode auxiliary proteins
                  that regulate viral fitness in hosts. Among these proteins, Nef has proven to play a major role in the progression of infections
                  with simian (SIV) and human (HIV) immunodeficiency viruses toward AIDS in primates (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>, <a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>, <a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a>, <a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a>, <a id="xref-ref-46-1" class="xref-bibr" href="#ref-46">46</a>, <a id="xref-ref-47-1" class="xref-bibr" href="#ref-47">47</a>, <a id="xref-ref-71-1" class="xref-bibr" href="#ref-71">71</a>). Single-round infection assays based on cell-free recombinant viruses also revealed that wild-type (WT) HIV type 1 (HIV-1)
                  and SIV are more infectious than mutants lacking Nef expression (<em>Δnef</em> viruses) (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>, <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>, <a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a>). The infectivity of <em>Δnef</em> viruses can be rescued by providing Nef in <em>trans</em> in virus-producing cells but not in target cells (<a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>). This Nef-dependent increase of infectivity observed in vitro might explain the high pathogenicity of WT HIV and SIV in
                  vivo compared with their <em>Δnef</em> counterparts.
               </p>
               <p id="p-3">Little is known about the mechanisms underlying the gain of infectivity conferred by Nef to HIV-1. One of the best-characterized
                  functions of Nef concerns its ability to affect the trafficking of proteins expressed at the cell surface. Nef was initially
                  shown to downregulate the cell surface expression levels of proteins such as CD4 and a subset of major histocompatibility
                  complex class I molecules (<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>, <a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>, <a id="xref-ref-76-1" class="xref-bibr" href="#ref-76">76</a>), but additional studies revealed that the expression of HIV but also SIV Nef promotes the downregulation of other cell surface
                  proteins, such as mature major histocompatibility complex class II molecules, CD28, CD8, CXCR4, and CCR5, and the transferrin
                  receptor (<a id="xref-ref-43-1" class="xref-bibr" href="#ref-43">43</a>, <a id="xref-ref-55-1" class="xref-bibr" href="#ref-55">55</a>, <a id="xref-ref-58-1" class="xref-bibr" href="#ref-58">58</a>, <a id="xref-ref-59-1" class="xref-bibr" href="#ref-59">59</a>, <a id="xref-ref-83-1" class="xref-bibr" href="#ref-83">83</a>, <a id="xref-ref-84-1" class="xref-bibr" href="#ref-84">84</a>, <a id="xref-ref-87-1" class="xref-bibr" href="#ref-87">87</a>; for a review, see reference <a id="xref-ref-48-1" class="xref-bibr" href="#ref-48">48</a>). The Nef-dependent downregulation of CD4 in virus-producing cells was shown to favor efficient HIV-1 envelope glycoprotein
                  incorporation into virions by preventing the formation of CD4/gp120 complexes at the cell surface (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>, <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>, <a id="xref-ref-73-1" class="xref-bibr" href="#ref-73">73</a>). An effect of Nef on T-cell activation leading to optimal conditions for HIV-1 and SIV replication was also suggested (<a id="xref-ref-75-1" class="xref-bibr" href="#ref-75">75</a>, <a id="xref-ref-81-1" class="xref-bibr" href="#ref-81">81</a>, <a id="xref-ref-92-1" class="xref-bibr" href="#ref-92">92</a>); however, it has been shown that Nef-dependent T-cell protein kinase activation and infectivity increase are two independent
                  properties of Nef (<a id="xref-ref-52-1" class="xref-bibr" href="#ref-52">52</a>, <a id="xref-ref-74-1" class="xref-bibr" href="#ref-74">74</a>). The fact that infectivity enhancement can be seen when viruses are produced in non-T cells, such as 293T, HeLa, or COS-7
                  cells, which do not express CD4, further suggests that mechanisms other than CD4 downregulation contribute to the Nef-dependent
                  increase of viral infectivity.
               </p>
               <p id="p-4">The route of viral entry was proposed to dictate the Nef dependence for optimal infectivity. Indeed, Nef increases the infectivity
                  of HIV-1-based recombinant viruses pseudotyped with envelope glycoproteins from HIV-1 or amphotropic murine leukemia virus
                  that promote membrane fusion and entry at the cell surface. On the contrary, Nef does not increase the infectivity of viruses
                  pseudotyped with the G protein of the vesicular stomatitis virus (VSV-G) for which fusion and entry take place after endocytosis
                  upon the acidification of endocytic vesicles (<a id="xref-ref-4-3" class="xref-bibr" href="#ref-4">4</a>, <a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>, <a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>, <a id="xref-ref-53-1" class="xref-bibr" href="#ref-53">53</a>, <a id="xref-ref-60-1" class="xref-bibr" href="#ref-60">60</a>). A specific role for Nef in HIV-1 entry into target cells at the fusion step has been suggested (<a id="xref-ref-72-1" class="xref-bibr" href="#ref-72">72</a>), but other studies reported that similar amounts of viral cores are released in target cells upon membrane fusion, regardless
                  of the presence of Nef during the assembly of viral particles (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>, <a id="xref-ref-60-2" class="xref-bibr" href="#ref-60">60</a>, <a id="xref-ref-86-1" class="xref-bibr" href="#ref-86">86</a>). Given that the Nef dependence for optimal infectivity of viral particles is relieved when target cells are treated with
                  drugs that disrupt the cytoskeleton, it has been suggested that Nef might facilitate postfusion events such as the trafficking
                  of viral cores through the cortical actin network (<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>), although this hypothesis has been recently challenged (<a id="xref-ref-65-1" class="xref-bibr" href="#ref-65">65</a>).
               </p>
               <p id="p-5">The incorporation of cellular proteins and accessory viral proteins into virions can have a positive or negative impact on
                  HIV infectivity. ICAM-1 (<em>i</em>ntra<em>c</em>ellular <em>a</em>dhesion <em>m</em>olecule <em>1</em>) expressed at the surface of virion-producing cells was shown to be incorporated into the viral membrane and to increase
                  infectivity of progeny virions by facilitating HIV-1 attachment to target cells (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a>, <a id="xref-ref-70-1" class="xref-bibr" href="#ref-70">70</a>). On the contrary, the Vif-dependent increase of HIV-1 infectivity relies on the specific exclusion of APOBEC3G (the cellular
                  <em>apo</em>lipoprotein <em>B</em> mRNA-<em>e</em>diting enzyme, <em>c</em>atalytic polypeptide-like <em>3G</em>) from virions during assembly (<a id="xref-ref-56-1" class="xref-bibr" href="#ref-56">56</a>, <a id="xref-ref-79-1" class="xref-bibr" href="#ref-79">79</a>, <a id="xref-ref-80-1" class="xref-bibr" href="#ref-80">80</a>; for a review, see reference <a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>). HIV and SIV Vpr proteins are incorporated into virions through an interaction with the p6 domain of the Gag precursor during
                  assembly (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>, <a id="xref-ref-49-1" class="xref-bibr" href="#ref-49">49</a>, <a id="xref-ref-50-1" class="xref-bibr" href="#ref-50">50</a>, <a id="xref-ref-64-1" class="xref-bibr" href="#ref-64">64</a>, <a id="xref-ref-78-1" class="xref-bibr" href="#ref-78">78</a>). Although Vpr is dispensable for optimal infection of dividing cells, the association of Vpr with viral cores of incoming
                  virions and with the preintegration complex was shown to play an important role in facilitating the infection of macrophages
                  (<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>, <a id="xref-ref-42-1" class="xref-bibr" href="#ref-42">42</a>, <a id="xref-ref-66-1" class="xref-bibr" href="#ref-66">66</a>, <a id="xref-ref-67-1" class="xref-bibr" href="#ref-67">67</a>, <a id="xref-ref-88-1" class="xref-bibr" href="#ref-88">88</a>).
               </p>
               <p id="p-6">Like the HIV and SIV Vpr accessory protein, Nef is incorporated into HIV and SIV virions (<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>, <a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a>, <a id="xref-ref-51-1" class="xref-bibr" href="#ref-51">51</a>, <a id="xref-ref-89-1" class="xref-bibr" href="#ref-89">89</a>). The analysis of WT and <em>Δnef</em> viruses failed to identify significant differences in the protein content of virions other than the presence of Nef itself
                  in WT viruses. This suggested that Nef molecules associated with the cores of incoming viruses might increase the efficiency
                  of postentry events, resulting in an overall increase of viral infectivity. In support of this hypothesis, Nef was shown to
                  increase the retrotranscription and expression of the integrated viral genome (<a id="xref-ref-4-4" class="xref-bibr" href="#ref-4">4</a>, <a id="xref-ref-77-1" class="xref-bibr" href="#ref-77">77</a>, <a id="xref-ref-92-2" class="xref-bibr" href="#ref-92">92</a>). However, since the infectivity of <em>Δnef</em> viruses cannot be rescued by providing Nef in target cells (<a id="xref-ref-4-5" class="xref-bibr" href="#ref-4">4</a>), the increase of infectivity might also rely on a Nef-dependent mechanism that takes place during viral biogenesis.
               </p>
               <p id="p-7">Here, we tried to determine whether the CD4-independent effect of Nef on HIV-1 infectivity depends on a specific function
                  of Nef molecules incorporated into viral particles or on a function of Nef during the assembly of the virus. To this aim,
                  we manipulated the proportionality between the amounts of Nef expressed during the assembly of the virus and the amounts of
                  Nef incorporated into viral particles. Our results show that the presence of intact Nef in viral particles is not sufficient
                  to increase HIV-1 infectivity.
               </p>
               <div class="section" id="sec-1">
                  <div class="section-nav"><a href="#abstract-1" title="ABSTRACT" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-10" title="RESULTS" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>MATERIALS AND METHODS</h2>
                  
                  <div id="sec-2" class="subsection">
                     
                     
                     <p id="p-8"><span class="inline-l2-heading">Cell culture.</span>293T and HeLa cells were obtained through the ATCC and grown in complete medium (Dulbecco's minimal essential medium supplemented
                        with 10% fetal calf serum [FCS], 100 IU of penicillin/ml, and 100 μg of streptomycin/ml [Invitrogen, Cergy-Pontoise, France]).
                        HeLa CD4 cells were obtained through the AIDS Research and Reference Reagents Program, Division of AIDS, NIAID, NIH, and grown
                        in complete medium supplemented with G418, 0.2 mg/ml (PAA, Austria). All cells were grown at 37°C with 5% CO<sub>2</sub>.
                     </p>
                     
                  </div>
                  
                  <div id="sec-3" class="subsection">
                     
                     
                     <p id="p-9"><span class="inline-l2-heading">Plasmids.</span>The construct encoding hemagglutinin (HA)-tagged HIV-1 Vpr<sub>LAI</sub> and green fluorescent protein-tagged Nef (Nef-GFP) were described elsewhere (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>, <a id="xref-ref-55-2" class="xref-bibr" href="#ref-55">55</a>). The pSRαNef<sub>LAI</sub> plasmids encoding HA-tagged WT HIV-1 Nef<sub>LAI</sub> and the LL<sub>165</sub>/AA mutant were a kind gift from H. Gottlinger (University of Massachusetts Medical School, Worcester, MA). The Nef <em>Xho</em> construct used in mock transfections was generated by digesting pSRαNef<sub>LAI</sub> with XhoI, followed by 3′ end filling and blunt-end ligation as described elsewhere (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>). The Nef-Vpr fusion was generated by standard overlapping PCR techniques. Briefly, the DNA sequences of Nef<sub>LAI</sub> and Vpr<sub>LAI</sub> were amplified separately with specific primers containing appropriate sequences to allow 3′-to-5′-end annealing of the two
                        PCR products in a second PCR and the generation of a Nef-Vpr fragment. The primers were also designed to allow the addition
                        of three glycine residues between Nef and Vpr, the HA tag at the C-terminal end of Vpr, and a BamHI restriction site 3′ to
                        the sequence of the HA tag. The final fragment was digested with XhoI and BamHI and subcloned into the pSRαNef<sub>LAI</sub> plasmid digested with the same restriction enzymes. Nef-M-Vpr and Nef-CS-Vpr were generated using the same strategy and appropriate
                        primers to allow the addition of the HA tag between Nef and Vpr. A glycine stretch or the ERQANFLGKI sequence corresponding
                        to the NC-p1 junction in the Gag polyprotein was inserted between the sequence of the HA tag and that of Vpr to generate Nef-M-Vpr
                        and Nef-CS-Vpr, respectively. The amino acids are numbered according to the sequence of HIV-1 Nef<sub>LAI</sub>.
                     </p>
                     
                  </div>
                  
                  <div id="sec-4" class="subsection">
                     
                     
                     <p id="p-10"><span class="inline-l2-heading">Viral production.</span>Single-round-infection HIV-1 virions carrying the GFP gene were made in 293T cells as follows. 293T cells were seeded in T75
                        flasks at a density of ∼2.5 × 10<sup>6</sup> cells/T75 flask and transfected after 16 h by the calcium phosphate precipitation technique with a DNA mix containing the
                        HIV-1-packaging plasmid (pCMVΔP1ΔenvpA), the HIV-1 vector encoding GFP (pHIvec2.GFP), the plasmids encoding the HIV-1 envelope
                        glycoprotein HXBc2 (pSVIIIenv), and pSRαNef<sub>LAI</sub> at concentrations of 3, 3, 1, and 1 μg/T75 flask, respectively. In the case where viruses were pseudotyped with VSV-G glycoprotein,
                        the pHCMV-G plasmid and a Rev-encoding plasmid (each at 1 μg/T75 flask) were used instead of pSVIIIenv HXBc2. The amounts
                        of plasmids encoding HA-tagged Vpr and Nef-Vpr constructs were adjusted to achieve expression levels similar to that of WT
                        Nef in producing cells. Elsewhere (see Fig. <a id="xref-fig-5-1" class="xref-fig" href="#F5">5</a> below), 1 μg of the construct encoding Nef-GFP was used. Cells were washed 6 and 24 h posttransfection and then cultured
                        in 10 ml of complete medium for 24 h, after which the supernatant was collected, spun to remove cell debris, filtered through
                        a 0.45-μm-pore-size filter, and either ultracentrifuged to pellet viruses or stored at −80°C until use in infectivity experiments.
                     </p>
                     
                  </div>
                  
                  <div id="sec-5" class="subsection">
                     
                     
                     <p id="p-11"><span class="inline-l2-heading">Ultracentrifugation.</span>Whole-virus pelleting was performed as follows. Supernatants obtained from 2.5 T75 flasks (25 ml/sample) were layered on 4
                        ml of phosphate-buffered saline (PBS) supplemented with 20% (wt/vol) sucrose in centrifuge tubes (Beckman Instruments, Inc.,
                        California). Samples were placed in swinging buckets on a Surespin 630 rotor and centrifuged at 4°C for 1.5 h at 27,000 rpm
                        in a Sorvall centrifuge. Viral cores were pelleted as described previously with minor modifications (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>). Briefly, supernatants (25 ml/sample) were centrifuged through a sucrose step gradient composed of 1.5 ml of PBS-sucrose
                        7.5%, 3.5 ml of PBS-sucrose 15%, and 3.5 ml of PBS-sucrose 30%. Igepal CA-630 (Sigma-Aldrich, Inc., MO) was added to the 15%
                        sucrose fraction (0.03%) to allow shedding of the viral membrane. Tubes were centrifuged as described above. Pelleted material
                        was resuspended in 80 μl of Laemmli sample buffer containing 5% of 2-mercaptoethanol (Sigma-Aldrich). The p24 contents of
                        viral particles were analyzed by resolving 2 μl of the samples by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
                        (SDS-PAGE). The incorporation of Nef, Vpr, and fusion protein into viral particles was analyzed by loading 20 μl of the samples
                        on the gels.
                     </p>
                     
                  </div>
                  
                  <div id="sec-6" class="subsection">
                     
                     
                     <p id="p-12"><span class="inline-l2-heading">Electrophoresis and Western blot analysis.</span>Virus-producing cells were solubilized and protein quantification was performed as described elsewhere (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>), except that Igepal CA-630 was used instead of 3-[(-cholamidopropyl)dimethylammonio]-2-hydroxyl-1-propanesulfonic acid (CHAPS)
                        in the lysis buffer. Cleared lysates containing ∼20 μg of total proteins were resolved by SDS-PAGE with 12% acrylamide (Sigma-Aldrich)
                        to analyze the expression levels of the molecular species described in the figure legends. Proteins were then visualized by
                        Western blotting followed by immunodetection with the following reagents. Rabbit polyclonal antibodies directed against HIV-1
                        p24 and p17 were obtained through the AIDS Research and Reference Reagents Program, Division of AIDS, NIAID, NIH and used
                        at dilutions of 1:10,000 and 1:1,000, respectively. The rat polyclonal antibody directed against the HA tag (clone 3-F10;
                        Roche Diagnostics GmbH, Germany) was used at a 1:500 dilution. GFP was detected with the rabbit polyclonal antibody (sc-8334;
                        Santa Cruz Biotechnology, Inc., California) used at a 1:500 dilution. Secondary reagents were peroxidase-coupled goat antibodies
                        directed against mouse or rat immunoglobulin G and used at a 1:2,000 dilution (Sigma-Aldrich).
                     </p>
                     
                  </div>
                  
                  <div id="sec-7" class="subsection">
                     
                     
                     <p id="p-13"><span class="inline-l2-heading">Infectivity assay.</span>Virus concentration in cell culture supernatant was measured by reverse transcriptase (RT) assay as described elsewhere (<a id="xref-ref-69-1" class="xref-bibr" href="#ref-69">69</a>). HeLa CD4 cells were seeded in 24-well plates at a density of 30,000 cells/well. After an overnight incubation, viruses
                        were added to the cells. The same RT counts were used for all the viruses used in the same experiment and varied from 200,000
                        to 400,000 RT cpm/ml between different experiments depending on the viral production. Sixteen hours postinfection, cells were
                        washed once and cultured for 48 h. Cells were then harvested with trypsin (Invitrogen), fixed in 500 μl of PBS supplemented
                        with formaldehyde at 3.7% (Sigma-Aldrich), and analyzed on a Cytomix FC500 cytometer (Beckman-Coulter, California). The percentage
                        of GFP-positive cells was determined by analyzing the data with the RXP analysis software. Depending on the viral input, Nef-negative
                        viruses infected between 5 and 10% of cells. Viral infectivity was calculated by normalizing the percentage of GFP-positive
                        cells of each sample to that obtained in cells infected with viruses produced in the absence of Nef.
                     </p>
                     
                  </div>
                  
                  <div id="sec-8" class="subsection">
                     
                     
                     <p id="p-14"><span class="inline-l2-heading">CD4 downregulation.</span>CD4 downregulation was analyzed in 293T cells coexpressing CD4 and various forms of Nef. 293T cells were seeded in T75 flasks
                        at a density of ∼2.5 × 10<sup>6</sup> cells/T75 and transfected after 16 h by the calcium phosphate precipitation technique with a DNA mix containing a GFP-coding
                        plasmid, plasmids coding WT CD4 or CD4 ΔCT, and the different Nef constructs at concentrations of 2, 4, and 7 μg/T75 flask,
                        respectively. Cells were washed 6 hours posttransfection and harvested after an additional 36-h incubation time. Cells were
                        detached with PBS and incubated in PBS supplemented with FCS at 2% (PBS-FCS). Cells (∼1 × 10<sup>6</sup>) were pelleted and incubated for 45 min on ice with 20 μl of a 1:2 dilution of the phycoerythrin-Cy5-coupled anti-CD4 antibody
                        (BD Biosciences, Belgium) in PBS-FCS. Cells were then washed twice in PBS-FCS and once in PBS, fixed in 500 μl of PBS supplemented
                        with formaldehyde at 3.7%, and analyzed on a Cytomix FC500 cytometer. Data were analyzed with the RXP analysis software. The
                        efficiency of CD4 downregulation was calculated for each construct as follows: (<em>p</em>CD4<sub>ΔCT</sub> construct/<em>p</em>CD4<sub>ΔCT</sub> Nef <em>Xho</em>) − (<em>p</em>CD4<sub>WT</sub> construct/<em>p</em>CD4<sub>WT</sub> Nef <em>Xho</em>), where <em>p</em> represents the percentage of cells coexpressing the indicated form of CD4 and Nef in the CD4<sup>high</sup> gate. The number obtained was normalized to that obtained in the presence of WT Nef and expressed as a percentage.
                     </p>
                     
                  </div>
                  
                  <div id="sec-9" class="subsection">
                     
                     
                     <p id="p-15"><span class="inline-l2-heading">Immunofluorescence.</span>HeLa cells were seeded in 24-well plates on coverslips at a density of ∼125,000 cells/well and transfected after 16 h by Lipofectamine
                        2000 (Invitrogen) with the indicated constructs at a concentration of 0.25 μg/well. Cells were washed 6 h posttransfection,
                        and coverslips were processed after a 24-h incubation time. Cells were washed twice in PBS and fixed for 30 min at 4°C in
                        PBS supplemented with paraformaldehyde at 4% (Sigma-Aldrich). The reaction was quenched for 10 min at room temperature with
                        PBS supplemented with 50 mM NH<sub>4</sub>Cl, and the mixture was washed twice in PBS supplemented with bovine serum albumin (BSA) at 0.1% (Sigma-Aldrich). Coverslips
                        were then incubated with PBS-BSA supplemented with Triton X-100 at 0.1% (Sigma-Aldrich) and the anti-HA 3F10 antibody at a
                        1:250 dilution. Cells were incubated 45 min on ice, washed twice in PBS-BSA, and incubated 45 min on ice in PBS-BSA supplemented
                        with Alexa488-coupled goat antibodies directed against rat immunoglobulin G (Invitrogen) at a 1:250 dilution. Coverslips were
                        then washed twice in PBS-BSA and once in PBS and inverted on glass slides in mounting medium containing 4′,6′-diamidino-2-phenylindole
                        (DAPI) (SlowFade; Invitrogen). Samples were examined under an epifluorescence microscope (Zeiss) with a cooled charge-coupled
                        device camera (Micromax; Roper Scientific, Evry, France) by use of a plan apochromatic 100× objective coupled to a piezo positioning
                        system allowing the acquisition of images in the <em>z</em> plane. The acquisition of images and the deconvolution of <em>z</em> stacks were done with MetaMorph (Universal Imaging, Downingtown, PA).
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-10">
                  <div class="section-nav"><a href="#sec-1" title="MATERIALS AND METHODS" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-16" title="DISCUSSION" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>RESULTS</h2>
                  
                  <div id="sec-11" class="subsection">
                     
                     
                     <p id="p-16"><span class="inline-l2-heading">Viral infectivity correlates with cellular and viral levels of Nef.</span>In order to determine whether HIV-1 infectivity enhancement requires the presence of Nef in virion-producing cells or in the
                        virus, we analyzed the correlation between the cellular amounts of Nef, the amounts of Nef incorporated into viral particles,
                        and viral infectivity. 293T cells were cotransfected with a fixed amount of plasmids required for the production of infectious
                        viral particles and increasing amounts of a plasmid encoding WT Nef fused to the HA tag at its C-terminal end (Fig. <a id="xref-fig-1-1" class="xref-fig" href="#F1">1</a>). As shown in Fig. <a id="xref-fig-2-1" class="xref-fig" href="#F2">2A</a>, left, this resulted in increasing amounts of Nef expressed in virus-producing cells (bottom) without affecting the expression
                        of the Gag polyprotein (top). The presence of Nef in virions pelleted from the cell culture supernatant was analyzed (Fig.
                        <a id="xref-fig-2-2" class="xref-fig" href="#F2">2A</a>, right). The expression of increasing amounts of Nef in virus-producing cells did not affect the amount of viral particles
                        released (Fig. <a id="xref-fig-2-3" class="xref-fig" href="#F2">2A</a>, right, top); however, it resulted in the cosedimentation of increasing amounts of Nef with virions (bottom). The presence
                        of several additional anti-HA reactive molecular species migrating faster than Nef in the pelleted material reflects the processing
                        of Nef by the viral protease (<a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a>) and confirms the presence of Nef in virions (Fig. <a id="xref-fig-2-4" class="xref-fig" href="#F2">2B</a>). The 18-kDa band likely derives from the processing of Nef at the WL<sub>58</sub> motif previously identified, while the 13-kDa band corresponds to the cleavage of Nef in its C-terminal domain (<a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a>, <a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a>). This fragment has been previously described (<a id="xref-ref-61-1" class="xref-bibr" href="#ref-61">61</a>), but the exact cleavage site has not been characterized yet. A minor band with an apparent molecular mass of 17 kDa was
                        also detected, suggesting the presence of an additional cleavage site C terminal to the WL<sub>58</sub> motif. We then analyzed the infectivity of viruses produced in the absence or in the presence of increasing amounts of Nef.
                        As shown in Fig. <a id="xref-fig-2-5" class="xref-fig" href="#F2">2C</a>, Nef enhanced HIV-1 infectivity up to fivefold. Moreover, viral infectivity was strictly correlated to the amount of Nef
                        expressed in the cells and incorporated into virions. From this correlation, one cannot conclude whether the increase of HIV-1
                        infectivity requires the presence of Nef in producer cells or in virions, and the necessity for uncoupling cellular and viral
                        levels of Nef is also highlighted.
                     </p>
                     <div id="F1" class="fig pos-float odd">
                        <div class="fig-inline"><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F1.expansion.html"><img alt="FIG. 1." src="F1.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F1.expansion.html">In this page</a></li>
                                 <li><a target="_top" class="in-nw-vis" href="http://jvi.asm.org/content/83/2/1093/F1.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="http://jvi.asm.org/powerpoint/83/2/1093/F1">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">FIG. 1.</span> 
                           <p id="p-40" class="first-child">Nef-based constructs used in this study. The various domains of the chimeric proteins are illustrated. Except for Nef-GFP,
                              all constructs are HA tagged to facilitate the immunodetection in Western blotting experiments. The HA tag was added to the
                              C-terminal ends of the proteins in order to preserve the myristoylation site of Nef. In the case of Nef-CS-Vpr, an HIV-1 protease
                              recognition motif corresponding to the NC-p1 junction in the Gag-Pol precursor was inserted between Nef and Vpr. The HA tag
                              was moved between Nef and this motif in order to visualize Nef fragments generated from the cleavage of the fusion protein
                              in the virus. A similar construct was also generated that contains a glycine stretch in place of the protease recognition
                              motif. Because the processing of Nef-CS-Vpr is supposed to release Nef fragments with the ERQAN sequence C terminal to the
                              HA tag, a Nef-ERQAN was also generated and analyzed in incorporation and infectivity experiments.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     <div id="F2" class="fig pos-float odd">
                        <div class="fig-inline"><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F2.expansion.html"><img alt="FIG. 2." src="F2.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F2.expansion.html">In this page</a></li>
                                 <li><a target="_top" class="in-nw-vis" href="http://jvi.asm.org/content/83/2/1093/F2.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="http://jvi.asm.org/powerpoint/83/2/1093/F2">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">FIG. 2.</span> 
                           <p id="p-41" class="first-child">Expression of Nef during HIV-1 production: impact on viral infectivity. GFP reporter viruses were produced in 293T cells in
                              the presence of increasing amounts of a Nef-coding plasmid (0.125 to 2 μg/T75 flasks). (A) Producer cells were solubilized
                              (left) and viruses were pelleted from the cell culture supernatant by ultracentrifugation (right). Samples were resolved by
                              SDS-PAGE and visualized by Western blotting (WB) followed by immunodetection with p24 (top)- and HA (bottom)-specific antibodies.
                              (B) Molecular species derived from the processing of Nef in mature viruses. The lane showing the incorporation of Nef into
                              viral particles (panel A, lane 10) is shown next to a schematic representation of Nef processed by HIV-1 protease. The position
                              of the processing sites (green arrows) was determined according to published data and the measurement of the mobility of the
                              anti-HA reactive proteins in the gel. (C) Viral infectivity was assayed with HeLa CD4 cells. HeLa CD4 cells were incubated
                              with increasing amounts of viruses (50 × 10<sup>3</sup> to 400 × 10<sup>3</sup> RT cpm/ml) produced in the presence of the indicated amounts of Nef-coding plasmid, and the percentages of GFP-positive cells
                              were measured by fluorescence-activated cell sorting 60 h postinfection.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-12" class="subsection">
                     
                     
                     <p id="p-17"><span class="inline-l2-heading">A Nef-Vpr fusion protein is efficiently incorporated into HIV-1 particles.</span>In order to uncouple the concentrations of Nef in producer cells and in virions, we generated a construct encoding a fusion
                        between Nef and Vpr. Previous work showed that more Vpr than Nef molecules are incorporated into virions (<a id="xref-ref-62-1" class="xref-bibr" href="#ref-62">62</a>, <a id="xref-ref-90-1" class="xref-bibr" href="#ref-90">90</a>), suggesting that a Nef-Vpr fusion would be more efficiently incorporated into virions than WT Nef. In addition, various
                        proteins fused to Vpr were shown to be efficiently incorporated into HIV-1 particles while retaining their original properties
                        (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>, <a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a>, <a id="xref-ref-57-1" class="xref-bibr" href="#ref-57">57</a>, <a id="xref-ref-93-1" class="xref-bibr" href="#ref-93">93</a>, <a id="xref-ref-94-1" class="xref-bibr" href="#ref-94">94</a>). Since the myristoylation of Nef is important for most of the functions of Nef investigated so far (<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>, <a id="xref-ref-82-1" class="xref-bibr" href="#ref-82">82</a>, <a id="xref-ref-91-1" class="xref-bibr" href="#ref-91">91</a>), we decided to fuse Vpr to the C-terminal end of Nef as depicted in Fig. <a id="xref-fig-1-2" class="xref-fig" href="#F1">1</a>.
                     </p>
                     
                     <p id="p-18">Viruses were produced in 293T cells expressing Nef, Nef-Vpr, or Vpr. Cell lysates and viruses were analyzed by Western blotting
                        as described for Fig. <a id="xref-fig-2-6" class="xref-fig" href="#F2">2</a>. Figure <a id="xref-fig-3-1" class="xref-fig" href="#F3">3A</a>, top, shows that the presence of Nef, Nef-Vpr, or Vpr affected neither the expression levels of Gag in producer cells (lanes
                        2, 4, and 6) nor the release of viral particles in the supernatant (lanes 8, 10, and 12). Traces of Nef and Nef-Vpr but no
                        Vpr was detected in the material pelleted from the supernatant of cells that did not express Gag-Pol (Fig. <a id="xref-fig-3-2" class="xref-fig" href="#F3">3A</a>, bottom, lanes 7 and 9). In the presence of Gag-Pol, however, significant amounts of Nef, Nef-Vpr, and Vpr cosedimented with
                        virions. The incorporation of these proteins into viral particles was further confirmed by the presence of cleaved forms of
                        Nef and Nef-Vpr (Fig. <a id="xref-fig-3-3" class="xref-fig" href="#F3">3A</a>, bottom, lanes 8 and 10). In agreement with published results (<a id="xref-ref-62-2" class="xref-bibr" href="#ref-62">62</a>, <a id="xref-ref-90-2" class="xref-bibr" href="#ref-90">90</a>), higher amounts of Vpr than of Nef were found to be incorporated into viral particles in spite of similar cellular expression
                        levels (Fig. <a id="xref-fig-3-4" class="xref-fig" href="#F3">3A</a>, bottom). Fusion of a Vpr sequence to the C-terminal end of Nef increased the amounts of Nef associated with viral particles
                        (Fig. <a id="xref-fig-3-5" class="xref-fig" href="#F3">3A</a>, bottom, compare lanes 8 and 10). Analysis of the molecular species derived from the Nef-Vpr fusion protein showed that the
                        processing of Nef-Vpr by HIV-1 protease resembles that of WT Nef (Fig. <a id="xref-fig-3-6" class="xref-fig" href="#F3">3B</a>, bottom). The fragments with apparent molecular masses of 26, 24, and 19 kDa probably reflect the cleavage of Nef-Vpr at
                        sites identified in Nef, but the fusion protein also appears to be susceptible to the viral protease at three additional sites,
                        generating 30-, 15-, and 13.5-kDa fragments.
                     </p>
                     <div id="F3" class="fig pos-float odd">
                        <div class="fig-inline"><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F3.expansion.html"><img alt="FIG. 3." src="F3.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F3.expansion.html">In this page</a></li>
                                 <li><a target="_top" class="in-nw-vis" href="http://jvi.asm.org/content/83/2/1093/F3.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="http://jvi.asm.org/powerpoint/83/2/1093/F3">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">FIG. 3.</span> 
                           <p id="p-42" class="first-child">Characterization of viruses produced in the presence of Nef, Nef-Vpr, and Vpr. 293T cells were cotransfected with Gag-Pol
                              in combination with either Nef, Nef-Vpr, or Vpr expression plasmids as indicated, along with the plasmids required for the
                              production of infectious particles. (A) Cells and viruses were analyzed as described in the Fig. <a id="xref-fig-2-7" class="xref-fig" href="#F2">2A</a> legend. (B) The processing of the Nef-Vpr fusion protein (bottom) was analyzed as described in the Fig. <a id="xref-fig-2-8" class="xref-fig" href="#F2">2B</a> legend and compared to that of WT Nef (top). Thick arrows indicate Nef-WT cleavage sites; thin arrows indicate three additional
                              sites where Nef-Vpr also appears to be susceptible to the viral protease. (C) HXBc2 Env- or VSV-G-pseudotyped viruses were
                              produced in the absence or in the presence of WT Nef or the Nef-Vpr fusion protein. Viral infectivity was measured as described
                              in the Fig. <a id="xref-fig-2-9" class="xref-fig" href="#F2">2C</a> legend and normalized to that of viruses produced in the presence of Nef <em>Xho</em>.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-19">We then compared the infectivities of viruses produced in the presence of Nef or Nef-Vpr. Figure <a id="xref-fig-3-7" class="xref-fig" href="#F3">3C</a> shows that viruses pseudotyped with the HIV-1 HXBc2 Env and produced in the presence of Nef were fivefold as infectious as
                        viruses produced in the absence of Nef (Nef <em>Xho</em>). On the contrary, no increase of infectivity was detected when viruses were produced in the presence of Nef-Vpr. Consistent
                        with previous results (<a id="xref-ref-5-2" class="xref-bibr" href="#ref-5">5</a>), VSV-G-pseudotyped viruses were equally infectious regardless of the presence of Nef. Of note is that the infectivity of
                        VSV-G-pseudotyped viruses produced in the presence of Nef-Vpr was identical to that of viruses produced in the absence or
                        in the presence of Nef. This means that the lack of effect of Nef-Vpr on the viral infectivity of HXBc2 Env-pseudotyped viruses
                        cannot be explained by a deleterious effect of Nef-Vpr on the overall viral fitness.
                     </p>
                     
                     <p id="p-20">Altogether, the results reported in Fig. <a id="xref-fig-3-8" class="xref-fig" href="#F3">3</a> show that the expression of the Nef-Vpr fusion protein in virus-producing cells is not able to restore the infectivity of
                        <em>Δnef</em> viruses, even if the fusion protein is efficiently incorporated and processed in viral particles.
                     </p>
                     
                  </div>
                  
                  <div id="sec-13" class="subsection">
                     
                     
                     <p id="p-21"><span class="inline-l2-heading">CD4 downregulation activity and subcellular localization of Nef-Vpr.</span>In order to gain insight into the functional differences between Nef and Nef-Vpr, we analyzed the ability of Nef-Vpr to downregulate
                        cell surface CD4 in 293T cells. Figure <a id="xref-fig-4-1" class="xref-fig" href="#F4">4A</a> shows that WT Nef was able to downregulate cell surface levels of WT CD4 but had no effect on CD4ΔCT (compare dot plots a
                        and b to f and g). The quantification of CD4 downregulation activity revealed that Nef-Vpr retained 40% of the activity of
                        WT Nef (Fig. <a id="xref-fig-4-2" class="xref-fig" href="#F4">4B</a>). As expected, Vpr and the well-characterized Nef LL<sub>165</sub>/AA mutant that fails to downregulate CD4 (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>, <a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>, <a id="xref-ref-41-1" class="xref-bibr" href="#ref-41">41</a>) displayed similar residual activities in this assay. The subcellular localization of these proteins was analyzed by immunofluorescence
                        microscopy. As shown in Fig. <a id="xref-fig-4-3" class="xref-fig" href="#F4">4C</a>, Vpr mostly localized to the nucleus (top) and an evident Vpr staining was detected around the nucleus in a DAPI-negative
                        area (top, insets), confirming the accumulation of Vpr at the nuclear envelope (<a id="xref-ref-29-2" class="xref-bibr" href="#ref-29">29</a>, <a id="xref-ref-88-2" class="xref-bibr" href="#ref-88">88</a>). The staining of Nef-expressing cells revealed a punctated pattern in the cytoplasm and at the plasma membrane (Fig. <a id="xref-fig-4-4" class="xref-fig" href="#F4">4C</a>, middle) compatible with endocytic vesicles and clathrin-coated pits as previously described (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>). As opposed to Vpr, Nef was detected neither in the nucleus nor at the nuclear envelope (Fig. <a id="xref-fig-4-5" class="xref-fig" href="#F4">4C</a>, middle, insets). The staining of cells expressing Nef-Vpr revealed punctated structures in the cytoplasm and at the plasma
                        membrane that were reminiscent of Nef; however, Nef-Vpr was also detected in a perinuclear region (Fig. <a id="xref-fig-4-6" class="xref-fig" href="#F4">4C</a>, bottom, insets) distinct from the nuclear envelope. These subtle differences in the localizations of Nef and Nef-Vpr might
                        explain why Nef-Vpr conserved a partial activity for CD4 downregulation but failed to increase viral infectivity.
                     </p>
                     <div id="F4" class="fig pos-float odd">
                        <div class="fig-inline"><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F4.expansion.html"><img alt="FIG. 4." src="F4.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F4.expansion.html">In this page</a></li>
                                 <li><a target="_top" class="in-nw-vis" href="http://jvi.asm.org/content/83/2/1093/F4.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="http://jvi.asm.org/powerpoint/83/2/1093/F4">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">FIG. 4.</span> 
                           <p id="p-43" class="first-child">CD4 downregulation activity and subcellular localization of Nef-Vpr. (A) Cell surface CD4 expression was analyzed with cells
                              coexpressing CD4 or CD4ΔCT along with Nef variants or Vpr as indicated. Cells were also cotransfected with a plasmid encoding
                              GFP to gate the analysis of cell surface CD4 expression on transfected cells. Dot plots of cells stained with a CD4-specific
                              antibody are shown. (B) Quantification of the CD4 downregulation activity of Nef variants measured as described for panel
                              A. (C) Cellular distribution of Nef, Nef-Vpr, and Vpr. HeLa cells were grown on coverslips and transfected with the indicated
                              HA-tagged constructs. Twenty-four hours posttransfection, cells were permeabilized and stained with an HA-specific antibody
                              and an Alexa488-coupled secondary antibody. Coverslips were transferred to slides in mounting medium supplemented with DAPI
                              and samples were analyzed by immunofluorescence microscopy followed by deconvolution as described in Materials and Methods.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-14" class="subsection">
                     
                     
                     <p id="p-22"><span class="inline-l2-heading">Vpr has a <em>cis</em>-inhibiting effect on the functions of Nef required for infectivity enhancement.</span>Figure <a id="xref-fig-4-7" class="xref-fig" href="#F4">4</a> demonstrates that Nef-Vpr retains 40% of the CD4 downregulation activity mediated by Nef but lacks the specific functions
                        that are important for viral infectivity enhancement. In order to determine whether this lack of function is specific to the
                        addition of the Vpr sequence to the C-terminal end of Nef, the activity of another Nef-based fusion protein containing the
                        GFP sequence (Fig. <a id="xref-fig-1-3" class="xref-fig" href="#F1">1</a>) was analyzed. It has been shown that the Nef-GFP fusion protein downregulates CD4 as efficiently as the native Nef protein
                        and that the same motifs of Nef are required for CD4 downregulation both for WT Nef and in the context of the Nef-GFP fusion
                        (<a id="xref-ref-11-2" class="xref-bibr" href="#ref-11">11</a>, <a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>, <a id="xref-ref-41-2" class="xref-bibr" href="#ref-41">41</a>). We thus characterized the Nef-GFP fusion protein in incorporation and infectivity assays. Figure <a id="xref-fig-5-2" class="xref-fig" href="#F5">5A</a> shows that Nef-GFP was efficiently incorporated and processed in virions and was also able to complement <em>Δnef</em> viruses in the infectivity assay (Fig. <a id="xref-fig-5-3" class="xref-fig" href="#F5">5B</a>). As described previously (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>), the introduction of the LL<sub>165</sub>/AA mutation in Nef severely altered the ability of Nef to increase viral infectivity. Therefore, these results indicate that
                        the Vpr sequence specifically inhibits the functions of Nef that are important for infectivity enhancement in the context
                        of the Nef-Vpr fusion protein.
                     </p>
                     <div id="F5" class="fig pos-float odd">
                        <div class="fig-inline"><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F5.expansion.html"><img alt="FIG. 5." src="F5.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F5.expansion.html">In this page</a></li>
                                 <li><a target="_top" class="in-nw-vis" href="http://jvi.asm.org/content/83/2/1093/F5.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="http://jvi.asm.org/powerpoint/83/2/1093/F5">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">FIG. 5.</span> 
                           <p id="p-44" class="first-child">Differential consequences of the addition of GFP or Vpr to the C-terminal end of Nef. (A) Viruses were produced in the presence
                              of WT Nef (left) or Nef-GFP (right). Cells and viruses were analyzed as described in the Fig. <a id="xref-fig-2-10" class="xref-fig" href="#F2">2A</a> legend. Nef-GFP was detected with GFP-specific antibodies. (B) Viral infectivities of viruses produced in the presence of
                              the indicated variants of Nef were analyzed as described in the Fig. <a id="xref-fig-2-11" class="xref-fig" href="#F2">2C</a> legend. (C) Viruses were produced in the presence of the indicated combination of Nef, Nef-Vpr, or Vpr. Cells and viruses
                              were analyzed as described in the Fig. <a id="xref-fig-2-12" class="xref-fig" href="#F2">2A</a> legend. Arrowheads point out the 27- and the 18-kDa forms of Nef. (D) Viral infectivities of viruses produced in the presence
                              of the indicated combinations of Nef, Nef-Vpr, and/or Vpr were measured as indicated in the Fig. <a id="xref-fig-2-13" class="xref-fig" href="#F2">2C</a> legend and normalized to that of viruses produced in the presence of Nef <em>Xho</em>.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-23">We then investigated the inhibitory effect of Vpr on these functions. To address this question, viruses were produced in cells
                        expressing Nef alone or in combination with Nef-Vpr or Vpr. The incorporation of these proteins and the infectivities of the
                        corresponding virions were analyzed. Consistent with previous results (Fig. <a id="xref-fig-3-9" class="xref-fig" href="#F3">3A</a>), Nef-Vpr and Vpr were incorporated into viral particles better than WT Nef with respect to their cellular expression levels
                        (Fig. <a id="xref-fig-5-4" class="xref-fig" href="#F5">5C</a>, bottom). The coexpression of Nef with either Nef-Vpr or Vpr resulted in the incorporation of both proteins in amounts comparable
                        to those of proteins expressed alone (Fig. <a id="xref-fig-5-5" class="xref-fig" href="#F5">5C</a>, bottom, compare lanes 8, 9, and 11 to lanes 8, 10, and 12). Regardless of the proteins coexpressed with Nef in producer
                        cells and coincorporated into viral particles, viruses produced in these conditions were threefold more infectious than viruses
                        produced in the absence of Nef (Fig. <a id="xref-fig-5-6" class="xref-fig" href="#F5">5D</a>). This indicates that in the context of the Nef-Vpr fusion, Vpr has a <em>cis-</em> but not a <em>trans</em>-inhibitory effect on the functions of Nef required for infectivity enhancement.
                     </p>
                     
                  </div>
                  
                  <div id="sec-15" class="subsection">
                     
                     
                     <p id="p-24"><span class="inline-l2-heading">Intravirion release of Nef from a Nef-CS-Vpr fusion protein does not rescue Nef functions essential for viral infectivity
                           enhancement.</span>The use of Vpr as a carrier results in a more efficient incorporation of the Nef-Vpr fusion protein into virions than WT Nef;
                        however, the Vpr sequence has a <em>cis</em>-inhibitory effect on Nef-mediated increase of viral infectivity. In order to release native Nef into virions after virus
                        maturation, we generated a Nef-Vpr fusion protein containing an HIV-1 protease-specific cleavage site between Nef and Vpr
                        (Nef-CS-Vpr). Another construct that included a glycine linker in place of the protease cleavage site (Nef-M-Vpr) was also
                        generated and used as a control (Fig. <a id="xref-fig-1-4" class="xref-fig" href="#F1">1</a>).
                     </p>
                     
                     <p id="p-25">Similar to what was observed with Nef-Vpr, high amounts of Nef-M-Vpr and Nef-CS-Vpr fusion protein were incorporated into
                        viral particles relative to amounts of WT Nef (Fig. <a id="xref-fig-6-1" class="xref-fig" href="#F6">6A</a>, bottom, lanes 4 to 6). Figure <a id="xref-fig-6-2" class="xref-fig" href="#F6">6B</a> also shows that the molecular species generated from the processing of the Nef-M-Vpr fusion protein were similar to those
                        generated from Nef-Vpr (Fig. <a id="xref-fig-3-10" class="xref-fig" href="#F3">3B</a>). The presence of a cleavage motif between Nef and Vpr modified the pattern of Nef-associated bands detected in virions (Fig.
                        <a id="xref-fig-6-3" class="xref-fig" href="#F6">6A</a>, bottom, compare lanes 5 and 6), indicating that Nef-CS-Vpr is efficiently processed at the protease cleavage site. The comparison
                        of the molecular species generated from the Nef-M-Vpr and Nef-CS-Vpr fusion proteins also revealed that most of the Nef-CS-Vpr
                        molecules incorporated into virions were cleaved between Nef and Vpr (Fig. <a id="xref-fig-6-4" class="xref-fig" href="#F6">6B</a>). Nef released from Nef-CS-Vpr was itself processed at sites previously identified in Nef. In addition, Fig. <a id="xref-fig-6-5" class="xref-fig" href="#F6">6A</a> shows that the molecular species generated from the processing of the Nef-CS-Vpr fusion protein cosedimented with viral cores
                        (bottom, compare lanes 4 to 6 and 7 to 9).
                     </p>
                     <div id="F6" class="fig pos-float odd">
                        <div class="fig-inline"><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F6.expansion.html"><img alt="FIG. 6." src="F6.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F6.expansion.html">In this page</a></li>
                                 <li><a target="_top" class="in-nw-vis" href="http://jvi.asm.org/content/83/2/1093/F6.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="http://jvi.asm.org/powerpoint/83/2/1093/F6">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">FIG. 6.</span> 
                           <p id="p-45" class="first-child">Characterization of a Nef-Vpr fusion protein containing a protease specific cleavage site between Nef and Vpr. (A) Viruses
                              were produced in the presence of WT Nef, Nef-M-Vpr, or Nef-CS-Vpr as indicated. Cells (left) and viruses (middle) were analyzed
                              as described in the Fig. <a id="xref-fig-2-14" class="xref-fig" href="#F2">2A</a> legend. Viral core purification (right) was performed by pelleting cell culture supernatant through a thin detergent layer
                              as indicated in Materials and Methods. Viral matrix and capsid were detected with p17- and p24-specific antibodies, respectively.
                              Film obtained with a short exposure time (30 s) is shown in order to better distinguish Nef-Vpr-derived fragments in whole
                              viruses and cores. This explains the weak signal obtained with Nef, since Nef-Vpr fusion proteins are better incorporated
                              than Nef. (B) The processing of the Nef-M-Vpr (top) and Nef-CS-Vpr (bottom) fusion proteins was analyzed as described in the
                              Fig. <a id="xref-fig-2-15" class="xref-fig" href="#F2">2B</a> legend. For Nef lanes, film obtained with a longer exposure time was used (5 min). The arrowhead indicates cleavage of the
                              Nef-CS-Vpr fusion protein at the HIV-1 protease-specific cleavage site (CS) introduced between Nef and VPR. The ability of
                              the indicated constructs to increase HIV-1 infectivity (C) and to downregulate cell surface CD4 (D) was analyzed as described
                              in the Fig. <a id="xref-fig-2-16" class="xref-fig" href="#F2">2</a> and <a id="xref-fig-4-8" class="xref-fig" href="#F4">4</a> legends, respectively.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-26">The ability of Nef-CS-Vpr to increase HIV-1 infectivity was analyzed. As shown in Fig. <a id="xref-fig-6-6" class="xref-fig" href="#F6">6C</a>, there was no significant infectivity enhancement when viruses were produced in the presence of either Nef-M-Vpr or Nef-CS-Vpr
                        compared with what was seen for viruses produced in the absence of Nef. The fact that both fusion proteins were 40% as efficient
                        as WT Nef in the CD4 downregulation assay (Fig. <a id="xref-fig-6-7" class="xref-fig" href="#F6">6D</a>) confirms that Nef-CS-Vpr selectively lacks functions important for HIV-1 infectivity enhancement.
                     </p>
                     
                     <p id="p-27">The ERQAN amino acids that remain fused to Nef following Nef-CS-Vpr processing likely account for the slight decrease in mobility
                        of the molecular species derived from Nef-CS-Vpr compared with what was seen for fragments generated from the processing of
                        WT Nef (Fig. <a id="xref-fig-6-8" class="xref-fig" href="#F6">6B</a>). In order to test this hypothesis and to rule out an inhibitory effect of these residues on the functions of Nef, an additional
                        fusion protein was generated by fusing the ERQAN stretch C terminal to the HA tag (Nef-ERQAN [Fig. <a id="xref-fig-1-5" class="xref-fig" href="#F1">1</a>]). Viruses were produced in the presence of Nef, Nef-ERQAN, and Nef-CS-Vpr and analyzed as described previously. The amounts
                        of Nef and Nef-CS-Vpr plasmids were adjusted to achieve similar incorporation levels of Nef into viruses, as opposed to what
                        was the case for Fig. <a id="xref-fig-3-11" class="xref-fig" href="#F3">3</a>, <a id="xref-fig-5-7" class="xref-fig" href="#F5">5</a>, and <a id="xref-fig-6-9" class="xref-fig" href="#F6">6</a>, where similar expression levels were achieved in producing cells. Figure <a id="xref-fig-7-1" class="xref-fig" href="#F7">7A</a> shows that Nef and Nef-ERQAN display similar expression and incorporation levels in producing cells and viruses, respectively
                        (bottom, lanes 2, 3, 8, and 9). As expected, the mobility of the Nef-ERQAN fusion was slightly lower than that of Nef both
                        in cell lysates (Fig. <a id="xref-fig-7-2" class="xref-fig" href="#F7">7A</a>, lanes 2 and 3) and after cleavage by the viral protease (Nef* and Nef-ERQAN*; lanes 8 and 9). Of note is that the ∼19-kDa
                        Nef fragment derived from the cleavage of the Nef-CS-Vpr by HIV-1 protease has an apparent molecular mass similar to that
                        of Nef-ERQAN (Fig. <a id="xref-fig-7-3" class="xref-fig" href="#F7">7A</a>, compare lanes 9 and 10), which further confirms that the cleavage of Nef-CS-Vpr releases a Nef-ERQAN fragment in the virus.
                        Figure <a id="xref-fig-7-4" class="xref-fig" href="#F7">7B</a> shows that viruses produced in the presence of Nef or Nef-ERQAN are more infectious than viruses produced in the absence
                        of Nef. Similar to what was previously observed, Nef-CS-Vpr failed to increase viral infectivity. In addition, this fusion
                        had a significant <em>trans</em>-inhibitory effect neither on Nef nor on Nef-ERQAN. Together, these results indicate that the presence of full-length Nef
                        as well as Nef fragments in viruses is not sufficient to increase HIV-1 infectivity.
                     </p>
                     <div id="F7" class="fig pos-float odd">
                        <div class="fig-inline"><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F7.expansion.html"><img alt="FIG. 7." src="F7.small.gif"></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a class="fig-inline-link" href="http://jvi.asm.org/content/83/2/1093/F7.expansion.html">In this page</a></li>
                                 <li><a target="_top" class="in-nw-vis" href="http://jvi.asm.org/content/83/2/1093/F7.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="http://jvi.asm.org/powerpoint/83/2/1093/F7">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">FIG. 7.</span> 
                           <p id="p-46" class="first-child">Characterization of the Nef-ERQAN fusion protein. (A) Viruses were produced in the presence of the indicated combination of
                              Nef, Nef-ERQAN, and Nef-CS-Vpr. Cells and viruses were analyzed as described in the Fig. <a id="xref-fig-2-17" class="xref-fig" href="#F2">2A</a> legend. The amounts of Nef-CS-Vpr-coding plasmid cotransfected with Nef and Nef-ERQAN were adjusted to achieve incorporation
                              of similar amounts of Nef-CS-Vpr and Nef in viral particles. (B) Viral infectivities of viruses produced in the presence of
                              the indicated combinations of Nef, Nef-ERQAN, and Nef-CS-Vpr were measured as indicated in the Fig. <a id="xref-fig-2-18" class="xref-fig" href="#F2">2C</a> legend and normalized to that of viruses produced in the presence of Nef <em>Xho</em>. * indicates a product cleaved by the viral protease.
                           </p>
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-16">
                  <div class="section-nav"><a href="#sec-10" title="RESULTS" class="prev-section-link"><span>Previous Section</span></a><a href="#ack-1" title="ACKNOWLEDGMENTS" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>DISCUSSION</h2>
                  
                  <p id="p-28">Soon after its initial description as a <em>ne</em>gative <em>f</em>actor of HIV-1 replication (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-54-1" class="xref-bibr" href="#ref-54">54</a>, <a id="xref-ref-63-1" class="xref-bibr" href="#ref-63">63</a>), Nef was shown to be required for optimal HIV and SIV infectivity in vitro and pathogenicity in vivo (<a id="xref-ref-4-6" class="xref-bibr" href="#ref-4">4</a>, <a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>, <a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>, <a id="xref-ref-28-2" class="xref-bibr" href="#ref-28">28</a>, <a id="xref-ref-37-2" class="xref-bibr" href="#ref-37">37</a>, <a id="xref-ref-39-2" class="xref-bibr" href="#ref-39">39</a>, <a id="xref-ref-40-2" class="xref-bibr" href="#ref-40">40</a>, <a id="xref-ref-46-2" class="xref-bibr" href="#ref-46">46</a>, <a id="xref-ref-47-2" class="xref-bibr" href="#ref-47">47</a>, <a id="xref-ref-71-2" class="xref-bibr" href="#ref-71">71</a>). Several mechanisms have been put forward to explain the gain of infectivity conferred by Nef to HIV-1; however, these mechanisms
                     fail to fit all the experimental systems in which the gain of infectivity can be observed. Our work questioned the relationship
                     between Nef incorporation into viral particles and viral infectivity. We characterized the ability of various Nef-based fusion
                     proteins to increase viral infectivity. We found that the incorporation of the Nef-CS-Vpr fusion protein and the efficient
                     release of full-length Nef and Nef fragments during virion maturation were not accompanied by an increase of viral infectivity.
                     These data demonstrate that the presence of Nef in viral particles is not sufficient to promote the increase of viral infectivity.
                  </p>
                  
                  <p id="p-29">The mechanism that drives Nef to the assembly platform of viral particles is not fully understood. Our results show that in
                     the absence of Gag-Pol, significant amounts of Nef, Nef-Vpr, and Nef-GFP (not shown), but not of Vpr, can be pelleted from
                     cell culture supernatants. This suggests that Nef can be found in vesicles secreted from cells independently of any other
                     viral component. Thus, the incorporation of Nef into viral particles might only reflect the propensity of Nef to associate
                     to membranes.
                  </p>
                  
                  <p id="p-30">The single-amino-acid substitution (G<sub>2</sub>/A) that prevents Nef myristoylation abolishes the incorporation of Nef into viral particles and severely affects its ability
                     to increase viral infectivity (<a id="xref-ref-8-2" class="xref-bibr" href="#ref-8">8</a>, <a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">13</a>, <a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>, <a id="xref-ref-61-2" class="xref-bibr" href="#ref-61">61</a>, <a id="xref-ref-91-2" class="xref-bibr" href="#ref-91">91</a>). Since myristoylation is also required for most of the other functions of Nef investigated so far, a direct link between
                     the lack of incorporation and the lack of effect on viral infectivity cannot be drawn. Extensive site-directed mutagenesis
                     has been performed to map the determinants on Nef responsible for its incorporation into virions. Mutation of the six lysine
                     and arginine residues located in the amino terminus of Nef prevents its incorporation (<a id="xref-ref-8-3" class="xref-bibr" href="#ref-8">8</a>, <a id="xref-ref-91-3" class="xref-bibr" href="#ref-91">91</a>). Despite retaining a WT-like myristoylation pattern, this mutant fails to increase viral infectivity and to downregulate
                     cell surface CD4 (<a id="xref-ref-8-4" class="xref-bibr" href="#ref-8">8</a>, <a id="xref-ref-91-4" class="xref-bibr" href="#ref-91">91</a>). Therefore, drawing definitive conclusions as to a particular phenotype is hazardous.
                  </p>
                  
                  <p id="p-31">On the contrary, several Nef mutants that are efficiently incorporated into viral particles but fail to increase viral infectivity
                     are reported in the literature. Such mutants do not allow one to discriminate whether Nef is required in producer cells or
                     in the virus. A mutation in Nef affecting incorporation without compromising viral infectivity enhancement would support the
                     hypothesis stating that the presence of Nef is required during viral production but not when progeny virions reach target
                     cells. One study shows that a mutant of Nef, with alanine substitution for the N-terminal acidic cluster (EEEE<sub>69</sub>/AAAA), is not detected in pelleted viruses yet potently increases viral infectivity (<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>); however, these results have been challenged in a recent study mentioning that this mutant is efficiently incorporated into
                     viral particles (<a id="xref-ref-68-1" class="xref-bibr" href="#ref-68">68</a>). These conflicting results leave the relevance of the incorporation of Nef into viral particles for infectivity increase
                     unanswered.
                  </p>
                  
                  <p id="p-32">Our results demonstrate that the presence of a functional form of Nef is important during the biogenesis of viral particles
                     and that the presence of WT Nef in viral particles does not suffice to increase viral infectivity. In a recent work published
                     by Qi and Aiken (<a id="xref-ref-68-2" class="xref-bibr" href="#ref-68">68</a>), Nef was fused to cyclophilin A (CypA) in order to control the incorporation of the resulting CypA-Nef fusion protein into
                     viral particles. The authors showed that the CypA-Nef fusion protein retains the Nef-specific ability to increase HIV-1 infectivity.
                     Of note is that when an alanine substitution was made for arginine 55 in CypA to prevent the CypA/Gag interaction, viruses
                     produced in the presence of the corresponding mutant (CypA.R55A-Nef) were as poorly infectious as viruses produced in the
                     absence of Nef. This indicates that Nef is not functional in the CypA.R55A-Nef construct and implies that it lacks the functions
                     required to increase HIV-1 infectivity. In light of our results, this indicates that the Nef-dependent increase of HIV-1 infectivity
                     requires a functional interaction between Nef and Gag. It also suggests that additional mechanisms are involved in virus-producing
                     cells in order to achieve optimal infectivity, since the presence of Nef in viral particles does not suffice to increase HIV-1
                     infectivity.
                  </p>
                  
                  <p id="p-33">If the Nef-dependent increase of HIV-1 infectivity reflects a specific function of Nef carried by incoming viruses to target
                     cells, the loss of function of the Nef-CS-Vpr fusion protein suggests that Nef fragments released from WT Nef and Nef-CS-Vpr
                     in mature virions might differ. It is well established that posttranslational modifications of Nef are required for Nef to
                     exert specific functions such as CD4 downregulation (<a id="xref-ref-31-2" class="xref-bibr" href="#ref-31">31</a>, <a id="xref-ref-45-1" class="xref-bibr" href="#ref-45">45</a>). Since Nef and Nef-Vpr do not have the same subcellular distribution, it is conceivable that Nef-Vpr does not undergo the
                     same posttranslational modifications as WT Nef. Differences in maturation patterns could be responsible for the specific loss
                     of infectivity enhancement of the Nef-Vpr fusion protein.
                  </p>
                  
                  <p id="p-34">Alternatively, Nef could increase viral infectivity by modifying viral particles in the course of their biogenesis. In agreement
                     with this hypothesis, Nef was found to alter the lipid composition of viral membranes (<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>, <a id="xref-ref-95-1" class="xref-bibr" href="#ref-95">95</a>, <a id="xref-ref-96-1" class="xref-bibr" href="#ref-96">96</a>) and to increase the incorporation of HIV-1 envelope glycoproteins into the membrane of the virus (<a id="xref-ref-6-2" class="xref-bibr" href="#ref-6">6</a>, <a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a>, <a id="xref-ref-73-2" class="xref-bibr" href="#ref-73">73</a>). Nef-associated kinases were also shown to phosphorylate HIV-1 matrix during viral assembly (<a id="xref-ref-85-1" class="xref-bibr" href="#ref-85">85</a>). Although these modifications might contribute to an overall increase of viral infectivity, additional mechanisms are likely
                     involved. Indeed, it has been shown that the efficiency of the fusion process is not affected by Nef (<a id="xref-ref-16-2" class="xref-bibr" href="#ref-16">16</a>, <a id="xref-ref-86-2" class="xref-bibr" href="#ref-86">86</a>) and that viruses harboring major deletions in matrix are as sensitive as WT viruses to the presence of Nef for optimal infectivity
                     (<a id="xref-ref-30-2" class="xref-bibr" href="#ref-30">30</a>).
                  </p>
                  
                  <p id="p-35">The LL<sub>165</sub> motif of Nef is involved in the interaction between Nef and clathrin-associated AP complexes and its integrity is required
                     for functions of Nef such as CD4 downregulation (<a id="xref-ref-11-3" class="xref-bibr" href="#ref-11">11</a>, <a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>, <a id="xref-ref-27-2" class="xref-bibr" href="#ref-27">27</a>, <a id="xref-ref-41-3" class="xref-bibr" href="#ref-41">41</a>, <a id="xref-ref-44-1" class="xref-bibr" href="#ref-44">44</a>). The fact that the LL<sub>165</sub>/AA mutant no longer enhances viral infectivity suggests that an interaction between Nef and AP complexes is directly involved
                     in this phenotype. It is possible that Nef affects the trafficking of cellular proteins and promotes their incorporation into
                     viral particles. Nef might also promote the exclusion of cellular factor from viral particles by redirecting these factors
                     away from HIV assembly platforms. A thorough proteomic analysis of WT and <em>Δnef</em> viruses should help identify differences that could explain the gain of infectivity conferred by Nef to WT viruses.
                  </p>
                  
                  <p id="p-36">Our study suggests that Nef might promote structural modifications of the virus or might itself be subjected to structural
                     modifications in order to increase HIV-1 infectivity. In either case, the Nef-dependent increase of HIV-1 infectivity should
                     be investigated in virion-producing cells. The determination of the binding partners of Nef and Nef-Vpr might reveal factors
                     that interact with Nef but fail to interact with Nef-Vpr. This might allow the identification of cellular factors specifically
                     hijacked by Nef in the virus-producing cells and target cells to optimize postfusion events.
                  </p>
                  
               </div>
               <div class="section ack" id="ack-1">
                  <div class="section-nav"><a href="#sec-16" title="DISCUSSION" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="FOOTNOTES" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>ACKNOWLEDGMENTS</h2>
                  
                  <p id="p-38">We thank Bastien Laumain for expert technical assistance in molecular biology.</p>
                  
                  <p id="p-39">This work was supported by grants from Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales (ANRS) and Sidaction
                     to S. Benichou and from Sidaction to S. Basmaciogullari. S. Basmaciogullari was supported successively by ANRS and INSERM
                     fellowships. N. Laguette is supported by a Ph.D. fellowship from the French Ministry of Research.
                  </p>
                  
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#ack-1" title="ACKNOWLEDGMENTS" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="REFERENCES" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>FOOTNOTES</h2>
                  <ul>
                     <ul class="history-list">
                        <li xmlns:hwp="http://schema.highwire.org/Journal" class="received" hwp:start="2008-07-31"><span class="received-label">Received </span>31 July 2008.
                        </li>
                        <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted" hwp:start="2008-10-26"><span class="accepted-label">Accepted </span>26 October 2008.
                        </li>
                     </ul>
                     <li class="corresp" id="corresp-1"><span class="corresp-label">*</span>Corresponding author. Mailing address: Institut Cochin, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France. Phone: (33)
                        1 40 51 65 80. Fax: (33) 1 40 51 65 70. E-mail for Stéphane Basmaciogullari: <a href="mailto:stephane.basmaciogullari@inserm.fr">stephane.basmaciogullari@inserm.fr</a>. E-mail for Serge Benichou: <a href="mailto:serge.benichou@inserm.fr">serge.benichou@inserm.fr</a></li>
                     <li class="fn fn-group-article-title" id="fn-1">
                        <p id="p-37"><a class="rev-xref" href="#xref-fn-1-1">↵</a><span class="fn-label">▿</span> Published ahead of print on 5 November 2008.
                        </p>
                     </li>
                  </ul>
               </div>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="FOOTNOTES" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder">&nbsp;</div>
                  </div>
                  <h2>REFERENCES</h2>
                  <ol class="cit-list">
                     <li><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text" id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.1">
                           <div class="cit-metadata"><cite><strong>Accola, M. A., A. A. Bukovsky, M. S. Jones, and H. G. Gottlinger.</strong> <span class="cit-pub-date">1999</span>. A conserved dileucine-containing motif in p6<sup><em>gag</em></sup> governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV<sub>mac</sub> and SIV<sub>agm</sub>. <span class="cit-source">J. Virol.</span> <span class="cit-vol">73</span><strong>:</strong><span class="cit-fpage">9992</span>-9999.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=73/12/9992" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2 in text" id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.2">
                           <div class="cit-metadata"><cite><strong>Accola, M. A., A. Ohagen, and H. G. Gottlinger.</strong> <span class="cit-pub-date">2000</span>. Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6<sup><em>gag</em></sup>. <span class="cit-source">J. Virol.</span> <span class="cit-vol">74</span><strong>:</strong><span class="cit-fpage">6198</span>-6202.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=74/13/6198" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3 in text" id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.3">
                           <div class="cit-metadata"><cite><strong>Ahmad, N., and S. Venkatesan.</strong> <span class="cit-pub-date">1988</span>. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. <span class="cit-source">Science</span> <span class="cit-vol">241</span><strong>:</strong><span class="cit-fpage">1481</span>-1485.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=241/4872/1481" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4 in text" id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.4">
                           <div class="cit-metadata"><cite><strong>Aiken, C., and D. Trono.</strong> <span class="cit-pub-date">1995</span>. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. <span class="cit-source">J. Virol.</span> <span class="cit-vol">69</span><strong>:</strong><span class="cit-fpage">5048</span>-5056.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=69/8/5048" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5 in text" id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.5">
                           <div class="cit-metadata"><cite><strong>Aiken, C.</strong> <span class="cit-pub-date">1997</span>. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1
                                 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. <span class="cit-source">J. Virol.</span> <span class="cit-vol">71</span><strong>:</strong><span class="cit-fpage">5871</span>-5877.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=71/8/5871" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6 in text" id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.6">
                           <div class="cit-metadata"><cite><strong>Arganaraz, E. R., M. Schindler, F. Kirchhoff, M. J. Cortes, and J. Lama.</strong> <span class="cit-pub-date">2003</span>. Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication.
                                 <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">278</span><strong>:</strong><span class="cit-fpage">33912</span>-33919.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=278/36/33912" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text" id="ref-7">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.7">
                           <div class="cit-metadata"><cite><strong>Basmaciogullari, S., B. Pacheco, S. Bour, and J. Sodroski.</strong> <span class="cit-pub-date">2006</span>. Specific interaction of CXCR4 with CD4 and CD8alpha: functional analysis of the CD4/CXCR4 interaction in the context of
                                 HIV-1 envelope glycoprotein-mediated membrane fusion. <span class="cit-source">Virology</span> <span class="cit-vol">353</span><strong>:</strong><span class="cit-fpage">52</span>-67.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/j.virol.2006.05.027&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=16808956&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text" id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.8">
                           <div class="cit-metadata"><cite><strong>Bentham, M., S. Mazaleyrat, and M. Harris.</strong> <span class="cit-pub-date">2006</span>. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1
                                 Nef protein. <span class="cit-source">J. Gen. Virol.</span> <span class="cit-vol">87</span><strong>:</strong><span class="cit-fpage">563</span>-571.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=vir&amp;resid=87/3/563" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text" id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.9">
                           <div class="cit-metadata"><cite><strong>Bertsch, C., D. Cluet, C. Beyer, L. Gloeckler, A. Cecile, J. P. Gut, and A. M. Aubertin.</strong> <span class="cit-pub-date">2002</span>. Properties of a chimeric simian-human immunodeficiency virus expressing an hybrid HIV-1 Nef/SIVmac Nef protein. <span class="cit-source">Arch. Virol.</span> <span class="cit-vol">147</span><strong>:</strong><span class="cit-fpage">1963</span>-1975.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1007/s00705-002-0857-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=12376757&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text" id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.10">
                           <div class="cit-metadata"><cite><strong>Bounou, S., J. F. Giguere, R. Cantin, C. Gilbert, M. Imbeault, G. Martin, and M. J. Tremblay.</strong> <span class="cit-pub-date">2004</span>. The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular
                                 context. <span class="cit-source">FASEB J.</span> <span class="cit-vol">18</span><strong>:</strong><span class="cit-fpage">1294</span>-1296.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=fasebj&amp;resid=04-1755fjev1" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text" id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.11">
                           <div class="cit-metadata"><cite><strong>Bresnahan, P. A., W. Yonemoto, S. Ferrell, D. Williams-Herman, R. Geleziunas, and W. C. Greene.</strong> <span class="cit-pub-date">1998</span>. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor.
                                 <span class="cit-source">Curr. Biol.</span> <span class="cit-vol">8</span><strong>:</strong><span class="cit-fpage">1235</span>-1238.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/S0960-9822(07)00517-9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=9811606&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text" id="ref-12">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.12">
                           <div class="cit-metadata"><cite><strong>Brugger, B., E. Krautkramer, N. Tibroni, C. E. Munte, S. Rauch, I. Leibrecht, B. Glass, S. Breuer, M. Geyer, H. G. Krausslich,
                                    H. R. Kalbitzer, F. T. Wieland, and O. T. Fackler.</strong> <span class="cit-pub-date">2007</span>. Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains.
                                 <span class="cit-source">Retrovirology</span> <span class="cit-vol">4</span><strong>:</strong><span class="cit-fpage">70</span>.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1186/1742-4690-4-70&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=17908312&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text" id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.13">
                           <div class="cit-metadata"><cite><strong>Bukovsky, A. A., T. Dorfman, A. Weimann, and H. G. Gottlinger.</strong> <span class="cit-pub-date">1997</span>. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. <span class="cit-source">J. Virol.</span> <span class="cit-vol">71</span><strong>:</strong><span class="cit-fpage">1013</span>-1018.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=71/2/1013" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text" id="ref-14">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.14">
                           <div class="cit-metadata"><cite><strong>Burtey, A., J. Z. Rappoport, J. Bouchet, S. Basmaciogullari, J. Guatelli, S. M. Simon, S. Benichou, and A. Benmerah.</strong> <span class="cit-pub-date">2007</span>. Dynamic interaction of HIV-1 Nef with the clathrin-mediated endocytic pathway at the plasma membrane. <span class="cit-source">Traffic</span> <span class="cit-vol">8</span><strong>:</strong><span class="cit-fpage">61</span>-76.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1111/j.1600-0854.2006.00512.x&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=17140399&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15 in text" id="ref-15">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.15">
                           <div class="cit-metadata"><cite><strong>Campbell, E. M., R. Nunez, and T. J. Hope.</strong> <span class="cit-pub-date">2004</span>. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity.
                                 <span class="cit-source">J. Virol.</span> <span class="cit-vol">78</span><strong>:</strong><span class="cit-fpage">5745</span>-5755.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=78/11/5745" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text" id="ref-16">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.16">
                           <div class="cit-metadata"><cite><strong>Cavrois, M., J. Neidleman, W. Yonemoto, D. Fenard, and W. C. Greene.</strong> <span class="cit-pub-date">2004</span>. HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. <span class="cit-source">Virology</span> <span class="cit-vol">328</span><strong>:</strong><span class="cit-fpage">36</span>-44.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/j.virol.2004.07.015&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=15380356&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text" id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.17">
                           <div class="cit-metadata"><cite><strong>Cavrois, M., C. De Noronha, and W. C. Greene.</strong> <span class="cit-pub-date">2002</span>. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. <span class="cit-source">Nat. Biotechnol.</span> <span class="cit-vol">20</span><strong>:</strong><span class="cit-fpage">1151</span>-1154.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1038/nbt745&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=12355096&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18 in text" id="ref-18">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.18">
                           <div class="cit-metadata"><cite><strong>Chakrabarti, L. A., K. J. Metzner, T. Ivanovic, H. Cheng, J. Louis-Virelizier, R. I. Connor, and C. Cheng-Mayer.</strong> <span class="cit-pub-date">2003</span>. A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Δnef increases viral
                                 replication. <span class="cit-source">J. Virol.</span> <span class="cit-vol">77</span><strong>:</strong><span class="cit-fpage">1245</span>-1256.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1128/JVI.77.2.1245-1256.2003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=12502842&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text" id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.19">
                           <div class="cit-metadata"><cite><strong>Chazal, N., G. Singer, C. Aiken, M. L. Hammarskjold, and D. Rekosh.</strong> <span class="cit-pub-date">2001</span>. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef
                                 for optimal infectivity. <span class="cit-source">J. Virol.</span> <span class="cit-vol">75</span><strong>:</strong><span class="cit-fpage">4014</span>-4018.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=75/8/4014" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text" id="ref-20">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.20">
                           <div class="cit-metadata"><cite><strong>Chen, Y. L., D. Trono, and D. Camaur.</strong> <span class="cit-pub-date">1998</span>. The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion
                                 infectivity. <span class="cit-source">J. Virol.</span> <span class="cit-vol">72</span><strong>:</strong><span class="cit-fpage">3178</span>-3184.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=72/4/3178" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text" id="ref-21">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.21">
                           <div class="cit-metadata"><cite><strong>Chiu, Y. L., and W. C. Greene.</strong> <span class="cit-pub-date">2008</span>. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
                                 <span class="cit-source">Annu. Rev. Immunol.</span> <span class="cit-vol">26</span><strong>:</strong><span class="cit-fpage">317</span>-353.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1146/annurev.immunol.26.021607.090350&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=18304004&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text" id="ref-22">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.22">
                           <div class="cit-metadata"><cite><strong>Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore.</strong> <span class="cit-pub-date">1999</span>. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from
                                 NK cells. <span class="cit-source">Immunity</span> <span class="cit-vol">10</span><strong>:</strong><span class="cit-fpage">661</span>-671.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/S1074-7613(00)80065-5&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=10403641&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23 in text" id="ref-23">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.23">
                           <div class="cit-metadata"><cite><strong>Coleman, S. H., R. Madrid, N. Van Damme, R. S. Mitchell, J. Bouchet, C. Servant, S. Pillai, S. Benichou, and J. C. Guatelli.</strong> <span class="cit-pub-date">2006</span>. Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the
                                 ExxxLL motif. <span class="cit-source">J. Virol.</span> <span class="cit-vol">80</span><strong>:</strong><span class="cit-fpage">1837</span>-1849.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=80/4/1837" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24 in text" id="ref-24">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.24">
                           <div class="cit-metadata"><cite><strong>Coleman, S. H., N. Van Damme, J. R. Day, C. M. Noviello, D. Hitchin, R. Madrid, S. Benichou, and J. C. Guatelli.</strong> <span class="cit-pub-date">2005</span>. Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexes.
                                 <span class="cit-source">J. Virol.</span> <span class="cit-vol">79</span><strong>:</strong><span class="cit-fpage">2066</span>-2078.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=79/4/2066" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25 in text" id="ref-25">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.25">
                           <div class="cit-metadata"><cite><strong>Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau.</strong> <span class="cit-pub-date">1995</span>. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. <span class="cit-source">Virology</span> <span class="cit-vol">206</span><strong>:</strong><span class="cit-fpage">935</span>-944.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1006/viro.1995.1016&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=7531918&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26 in text" id="ref-26">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.26">
                           <div class="cit-metadata"><cite><strong>Cortes, M. J., F. Wong-Staal, and J. Lama.</strong> <span class="cit-pub-date">2002</span>. Cell surface CD4 interferes with the infectivity of HIV-1 particles released from T cells. <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">277</span><strong>:</strong><span class="cit-fpage">1770</span>-1779.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=277/3/1770" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27 in text" id="ref-27">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.27">
                           <div class="cit-metadata"><cite><strong>Craig, H. M., M. W. Pandori, and J. C. Guatelli.</strong> <span class="cit-pub-date">1998</span>. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal
                                 viral infectivity. <span class="cit-source">Proc. Natl. Acad. Sci. USA</span> <span class="cit-vol">95</span><strong>:</strong><span class="cit-fpage">11229</span>-11234.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=95/19/11229" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28 in text" id="ref-28">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.28">
                           <div class="cit-metadata"><cite><strong>Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett,
                                    C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton,
                                    and J. Mills.</strong> <span class="cit-pub-date">1995</span>. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. <span class="cit-source">Science</span> <span class="cit-vol">270</span><strong>:</strong><span class="cit-fpage">988</span>-991.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=sci&amp;resid=270/5238/988" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29 in text" id="ref-29">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.29">
                           <div class="cit-metadata"><cite><strong>Depienne, C., P. Roques, C. Creminon, L. Fritsch, R. Casseron, D. Dormont, C. Dargemont, and S. Benichou.</strong> <span class="cit-pub-date">2000</span>. Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency
                                 viruses. <span class="cit-source">Exp. Cell Res.</span> <span class="cit-vol">260</span><strong>:</strong><span class="cit-fpage">387</span>-395.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1006/excr.2000.5016&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=11035935&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30 in text" id="ref-30">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.30">
                           <div class="cit-metadata"><cite><strong>Dorfman, T., E. Popova, M. Pizzato, and H. G. Gottlinger.</strong> <span class="cit-pub-date">2002</span>. Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. <span class="cit-source">J. Virol.</span> <span class="cit-vol">76</span><strong>:</strong><span class="cit-fpage">6857</span>-6862.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=76/13/6857" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31 in text" id="ref-31">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.31">
                           <div class="cit-metadata"><cite><strong>Fackler, O. T., A. Moris, N. Tibroni, S. I. Giese, B. Glass, O. Schwartz, and H. G. Krausslich.</strong> <span class="cit-pub-date">2006</span>. Functional characterization of HIV-1 Nef mutants in the context of viral infection. <span class="cit-source">Virology</span> <span class="cit-vol">351</span><strong>:</strong><span class="cit-fpage">322</span>-339.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/j.virol.2006.03.044&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=16684552&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32 in text" id="ref-32">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.32">
                           <div class="cit-metadata"><cite><strong>Fletcher, T. M., III, M. A. Soares, S. McPhearson, H. Hui, M. Wiskerchen, M. A. Muesing, G. M. Shaw, A. D. Leavitt, J. D.
                                    Boeke, and B. H. Hahn.</strong> <span class="cit-pub-date">1997</span>. Complementation of integrase function in HIV-1 virions. <span class="cit-source">EMBO J.</span> <span class="cit-vol">16</span><strong>:</strong><span class="cit-fpage">5123</span>-5138.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1093/emboj/16.16.5123&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=9305653&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33 in text" id="ref-33">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.33">
                           <div class="cit-metadata"><cite><strong>Forshey, B. M., and C. Aiken.</strong> <span class="cit-pub-date">2003</span>. Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein
                                 complex. <span class="cit-source">J. Virol.</span> <span class="cit-vol">77</span><strong>:</strong><span class="cit-fpage">4409</span>-4414.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=77/7/4409" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference 34 in text" id="ref-34">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.34">
                           <div class="cit-metadata"><cite><strong>Fortin, J. F., R. Cantin, G. Lamontagne, and M. Tremblay.</strong> <span class="cit-pub-date">1997</span>. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance
                                 viral infectivity. <span class="cit-source">J. Virol.</span> <span class="cit-vol">71</span><strong>:</strong><span class="cit-fpage">3588</span>-3596.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=71/5/3588" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35 in text" id="ref-35">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.35">
                           <div class="cit-metadata"><cite><strong>Freund, J., R. Kellner, J. Konvalinka, V. Wolber, H. G. Krausslich, and H. R. Kalbitzer.</strong> <span class="cit-pub-date">1994</span>. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. <span class="cit-source">Eur. J. Biochem.</span> <span class="cit-vol">223</span><strong>:</strong><span class="cit-fpage">589</span>-593.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=8055930&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference 36 in text" id="ref-36">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.36">
                           <div class="cit-metadata"><cite><strong>Gaedigk-Nitschko, K., A. Schon, G. Wachinger, V. Erfle, and B. Kohleisen.</strong> <span class="cit-pub-date">1995</span>. Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. <span class="cit-source">FEBS Lett.</span> <span class="cit-vol">357</span><strong>:</strong><span class="cit-fpage">275</span>-278.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/0014-5793(94)01370-G&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=7835426&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37 in text" id="ref-37">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.37">
                           <div class="cit-metadata"><cite><strong>Garcia, J. V., and J. L. Foster.</strong> <span class="cit-pub-date">1996</span>. Structural and functional correlates between HIV-1 and SIV Nef isolates. <span class="cit-source">Virology</span> <span class="cit-vol">226</span><strong>:</strong><span class="cit-fpage">161</span>-166.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1006/viro.1996.0642&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=8955034&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38 in text" id="ref-38">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.38">
                           <div class="cit-metadata"><cite><strong>Garcia, J. V., and A. D. Miller.</strong> <span class="cit-pub-date">1991</span>. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. <span class="cit-source">Nature</span> <span class="cit-vol">350</span><strong>:</strong><span class="cit-fpage">508</span>-511.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1038/350508a0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=2014052&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference 39 in text" id="ref-39">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.39">
                           <div class="cit-metadata"><cite><strong>Gorry, P. R., M. Churchill, J. Learmont, C. Cherry, W. B. Dyer, S. L. Wesselingh, and J. S. Sullivan.</strong> <span class="cit-pub-date">2007</span>. Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo. <span class="cit-source">J. Acquir. Immune Defic. Syndr.</span> <span class="cit-vol">46</span><strong>:</strong><span class="cit-fpage">390</span>-394.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=17993857&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference 40 in text" id="ref-40">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.40">
                           <div class="cit-metadata"><cite><strong>Gorry, P. R., D. A. McPhee, E. Verity, W. B. Dyer, S. L. Wesselingh, J. Learmont, J. S. Sullivan, M. Roche, J. J. Zaunders,
                                    D. Gabuzda, S. M. Crowe, J. Mills, S. R. Lewin, B. J. Brew, A. L. Cunningham, and M. J. Churchill.</strong> <span class="cit-pub-date">2007</span>. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. <span class="cit-source">Retrovirology</span> <span class="cit-vol">4</span><strong>:</strong><span class="cit-fpage">66</span>.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1186/1742-4690-4-66&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=17888184&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-41-1" title="View reference 41 in text" id="ref-41">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.41">
                           <div class="cit-metadata"><cite><strong>Greenberg, M., L. DeTulleo, I. Rapoport, J. Skowronski, and T. Kirchhausen.</strong> <span class="cit-pub-date">1998</span>. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. <span class="cit-source">Curr. Biol.</span> <span class="cit-vol">8</span><strong>:</strong><span class="cit-fpage">1239</span>-1242.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/S0960-9822(07)00518-0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=9811611&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference 42 in text" id="ref-42">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.42">
                           <div class="cit-metadata"><cite><strong>Heinzinger, N. K., M. I. Bukinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M. A. Lee, H. E. Gendelman, L. Ratner, M.
                                    Stevenson, and M. Emerman.</strong> <span class="cit-pub-date">1994</span>. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing
                                 host cells. <span class="cit-source">Proc. Natl. Acad. Sci. USA</span> <span class="cit-vol">91</span><strong>:</strong><span class="cit-fpage">7311</span>-7315.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=91/15/7311" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-43-1" title="View reference 43 in text" id="ref-43">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.43">
                           <div class="cit-metadata"><cite><strong>Hrecka, K., T. Swigut, M. Schindler, F. Kirchhoff, and J. Skowronski.</strong> <span class="cit-pub-date">2005</span>. Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal
                                 derived factor 1. <span class="cit-source">J. Virol.</span> <span class="cit-vol">79</span><strong>:</strong><span class="cit-fpage">10650</span>-10659.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=79/16/10650" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference 44 in text" id="ref-44">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.44">
                           <div class="cit-metadata"><cite><strong>Janvier, K., Y. Kato, M. Boehm, J. R. Rose, J. A. Martina, B. Y. Kim, S. Venkatesan, and J. S. Bonifacino.</strong> <span class="cit-pub-date">2003</span>. Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3
                                 hemicomplexes. <span class="cit-source">J. Cell Biol.</span> <span class="cit-vol">163</span><strong>:</strong><span class="cit-fpage">1281</span>-1290.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jcb&amp;resid=163/6/1281" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-45-1" title="View reference 45 in text" id="ref-45">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.45">
                           <div class="cit-metadata"><cite><strong>Jin, Y. J., C. Y. Cai, X. Zhang, and S. J. Burakoff.</strong> <span class="cit-pub-date">2008</span>. Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation. <span class="cit-source">J. Immunol.</span> <span class="cit-vol">180</span><strong>:</strong><span class="cit-fpage">7878</span>-7886.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jimmunol&amp;resid=180/12/7878" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-46-1" title="View reference 46 in text" id="ref-46">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.46">
                           <div class="cit-metadata"><cite><strong>Kestler, H. W., III, D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers.</strong> <span class="cit-pub-date">1991</span>. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. <span class="cit-source">Cell</span> <span class="cit-vol">65</span><strong>:</strong><span class="cit-fpage">651</span>-662.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/0092-8674(91)90097-I&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=2032289&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-47-1" title="View reference 47 in text" id="ref-47">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.47">
                           <div class="cit-metadata"><cite><strong>Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers.</strong> <span class="cit-pub-date">1995</span>. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. <span class="cit-source">N. Engl. J. Med.</span> <span class="cit-vol">332</span><strong>:</strong><span class="cit-fpage">228</span>-232.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1056/NEJM199501263320405&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=7808489&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-48-1" title="View reference 48 in text" id="ref-48">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.48">
                           <div class="cit-metadata"><cite><strong>Kirchhoff, F., M. Schindler, A. Specht, N. Arhel, and J. Munch.</strong> <span class="cit-pub-date">2008</span>. Role of Nef in primate lentiviral immunopathogenesis. <span class="cit-source">Cell. Mol. Life Sci.</span> <span class="cit-vol">65</span><strong>:</strong><span class="cit-fpage">2621</span>-2636.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1007/s00018-008-8094-2&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=18438604&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-49-1" title="View reference 49 in text" id="ref-49">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.49">
                           <div class="cit-metadata"><cite><strong>Kondo, E., and H. G. Gottlinger.</strong> <span class="cit-pub-date">1996</span>. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus
                                 type 1 Vpr. <span class="cit-source">J. Virol.</span> <span class="cit-vol">70</span><strong>:</strong><span class="cit-fpage">159</span>-164.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=70/1/159" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-50-1" title="View reference 50 in text" id="ref-50">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.50">
                           <div class="cit-metadata"><cite><strong>Kondo, E., F. Mammano, E. A. Cohen, and H. G. Gottlinger.</strong> <span class="cit-pub-date">1995</span>. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral
                                 particles. <span class="cit-source">J. Virol.</span> <span class="cit-vol">69</span><strong>:</strong><span class="cit-fpage">2759</span>-2764.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=69/5/2759" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-51-1" title="View reference 51 in text" id="ref-51">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.51">
                           <div class="cit-metadata"><cite><strong>Kotov, A., J. Zhou, P. Flicker, and C. Aiken.</strong> <span class="cit-pub-date">1999</span>. Association of Nef with the human immunodeficiency virus type 1 core. <span class="cit-source">J. Virol.</span> <span class="cit-vol">73</span><strong>:</strong><span class="cit-fpage">8824</span>-8830.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=73/10/8824" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-52-1" title="View reference 52 in text" id="ref-52">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.52">
                           <div class="cit-metadata"><cite><strong>Luo, T., R. A. Livingston, and J. V. Garcia.</strong> <span class="cit-pub-date">1997</span>. Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine
                                 kinase. <span class="cit-source">J. Virol.</span> <span class="cit-vol">71</span><strong>:</strong><span class="cit-fpage">9524</span>-9530.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=71/12/9524" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-53-1" title="View reference 53 in text" id="ref-53">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.53">
                           <div class="cit-metadata"><cite><strong>Luo, T., J. L. Douglas, R. L. Livingston, and J. V. Garcia.</strong> <span class="cit-pub-date">1998</span>. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer
                                 systems. <span class="cit-source">Virology</span> <span class="cit-vol">241</span><strong>:</strong><span class="cit-fpage">224</span>-233.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1006/viro.1997.8966&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=9499797&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-54-1" title="View reference 54 in text" id="ref-54">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.54">
                           <div class="cit-metadata"><cite><strong>Luciw, P. A., C. Cheng-Mayer, and J. A. Levy.</strong> <span class="cit-pub-date">1987</span>. Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. <span class="cit-source">Proc. Natl. Acad. Sci. USA</span> <span class="cit-vol">84</span><strong>:</strong><span class="cit-fpage">1434</span>-1438.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=84/5/1434" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-55-1" title="View reference 55 in text" id="ref-55">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.55">
                           <div class="cit-metadata"><cite><strong>Madrid, R., K. Janvier, D. Hitchin, J. Day, S. Coleman, C. Noviello, J. Bouchet, A. Benmerah, J. Guatelli, and S. Benichou.</strong> <span class="cit-pub-date">2005</span>. Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">280</span><strong>:</strong><span class="cit-fpage">5032</span>-5044.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=280/6/5032" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-56-1" title="View reference 56 in text" id="ref-56">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.56">
                           <div class="cit-metadata"><cite><strong>Mariani, R., D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N. R. Landau.</strong> <span class="cit-pub-date">2003</span>. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. <span class="cit-source">Cell</span> <span class="cit-vol">114</span><strong>:</strong><span class="cit-fpage">21</span>-31.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/S0092-8674(03)00515-4&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=12859895&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-57-1" title="View reference 57 in text" id="ref-57">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.57">
                           <div class="cit-metadata"><cite><strong>McDonald, D., M. A. Vodicka, G. Lucero, T. M. Svitkina, G. G. Borisy, M. Emerman, and T. J. Hope.</strong> <span class="cit-pub-date">2002</span>. Visualization of the intracellular behavior of HIV in living cells. <span class="cit-source">J. Cell Biol.</span> <span class="cit-vol">159</span><strong>:</strong><span class="cit-fpage">441</span>-452.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jcb&amp;resid=159/3/441" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-58-1" title="View reference 58 in text" id="ref-58">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.58">
                           <div class="cit-metadata"><cite><strong>Michel, N., K. Ganter, S. Venzke, J. Bitzegeio, O. T. Fackler, and O. T. Keppler.</strong> <span class="cit-pub-date">2006</span>. The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels
                                 that acts independently of classical motifs for receptor endocytosis and Galphai signaling. <span class="cit-source">Mol. Biol. Cell</span> <span class="cit-vol">17</span><strong>:</strong><span class="cit-fpage">3578</span>-3590.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=molbiolcell&amp;resid=17/8/3578" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-59-1" title="View reference 59 in text" id="ref-59">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.59">
                           <div class="cit-metadata"><cite><strong>Michel, N., I. Allespach, S. Venzke, O. T. Fackler, and O. T. Keppler.</strong> <span class="cit-pub-date">2005</span>. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface
                                 CCR5 and CD4. <span class="cit-source">Curr. Biol.</span> <span class="cit-vol">15</span><strong>:</strong><span class="cit-fpage">714</span>-723.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/j.cub.2005.02.058&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=15854903&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-60-1" title="View reference 60 in text" id="ref-60">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.60">
                           <div class="cit-metadata"><cite><strong>Miller, M. D., M. T. Warmerdam, K. A. Page, M. B. Feinberg, and W. C. Greene.</strong> <span class="cit-pub-date">1995</span>. Expression of the human immunodeficiency virus type 1 (HIV-1) <em>nef</em> gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. <span class="cit-source">J. Virol.</span> <span class="cit-vol">69</span><strong>:</strong><span class="cit-fpage">579</span>-584.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=69/1/579" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-61-1" title="View reference 61 in text" id="ref-61">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.61">
                           <div class="cit-metadata"><cite><strong>Miller, M. D., M. T. Warmerdam, S. S. Ferrell, R. Benitez, and W. C. Greene.</strong> <span class="cit-pub-date">1997</span>. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral
                                 infectivity. <span class="cit-source">Virology</span> <span class="cit-vol">234</span><strong>:</strong><span class="cit-fpage">215</span>-225.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1006/viro.1997.8641&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=9268152&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-62-1" title="View reference 62 in text" id="ref-62">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.62">
                           <div class="cit-metadata"><cite><strong>Muller, B., U. Tessmer, U. Schubert, and H. G. Krausslich.</strong> <span class="cit-pub-date">2000</span>. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than Gag
                                 and is phosphorylated in infected cells. <span class="cit-source">J. Virol.</span> <span class="cit-vol">74</span><strong>:</strong><span class="cit-fpage">9727</span>-9731.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=74/20/9727" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-63-1" title="View reference 63 in text" id="ref-63">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.63">
                           <div class="cit-metadata"><cite><strong>Niederman, T. M., B. J. Thielan, and L. Ratner.</strong> <span class="cit-pub-date">1989</span>. Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. <span class="cit-source">Proc. Natl. Acad. Sci. USA</span> <span class="cit-vol">86</span><strong>:</strong><span class="cit-fpage">1128</span>-1132.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=86/4/1128" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-64-1" title="View reference 64 in text" id="ref-64">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.64">
                           <div class="cit-metadata"><cite><strong>Paxton, W., R. I. Connor, and N. R. Landau.</strong> <span class="cit-pub-date">1993</span>. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of Gag and mutational
                                 analysis. <span class="cit-source">J. Virol.</span> <span class="cit-vol">67</span><strong>:</strong><span class="cit-fpage">7229</span>-7237.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=67/12/7229" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-65-1" title="View reference 65 in text" id="ref-65">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.65">
                           <div class="cit-metadata"><cite><strong>Pizzato, M., E. Popova, and H. G. Gottlinger.</strong> <span class="cit-pub-date">2008</span>. Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. <span class="cit-source">J. Virol.</span><span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1128/JVI.01150-08</span>.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=82/21/10811" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-66-1" title="View reference 66 in text" id="ref-66">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.66">
                           <div class="cit-metadata"><cite><strong>Popov, S., M. Rexach, L. Ratner, G. Blobel, and M. Bukrinsky.</strong> <span class="cit-pub-date">1998</span>. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">273</span><strong>:</strong><span class="cit-fpage">13347</span>-13352.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=273/21/13347" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-67-1" title="View reference 67 in text" id="ref-67">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.67">
                           <div class="cit-metadata"><cite><strong>Popov, S., M. Rexach, G. Zybarth, N. Reiling, M. A. Lee, L. Ratner, C. M. Lane, M. S. Moore, G. Blobel, and M. Bukrinsky.</strong> <span class="cit-pub-date">1998</span>. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. <span class="cit-source">EMBO J.</span> <span class="cit-vol">17</span><strong>:</strong><span class="cit-fpage">909</span>-917.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1093/emboj/17.4.909&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=9463369&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-68-1" title="View reference 68 in text" id="ref-68">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.68">
                           <div class="cit-metadata"><cite><strong>Qi, M., and C. Aiken.</strong> <span class="cit-pub-date">2008</span>. Nef enhances HIV-1 infectivity via association with the virus assembly complex. <span class="cit-source">Virology</span> <span class="cit-vol">373</span><strong>:</strong><span class="cit-fpage">287</span>-297.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/j.virol.2007.12.001&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=18191978&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-69-1" title="View reference 69 in text" id="ref-69">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.69">
                           <div class="cit-metadata"><cite><strong>Rho, H. M., B. Poiesz, F. W. Ruscetti, and R. C. Gallo.</strong> <span class="cit-pub-date">1981</span>. Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma
                                 cell line. <span class="cit-source">Virology</span> <span class="cit-vol">112</span><strong>:</strong><span class="cit-fpage">355</span>-360.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/0042-6822(81)90642-5&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=6166122&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-70-1" title="View reference 70 in text" id="ref-70">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.70">
                           <div class="cit-metadata"><cite><strong>Rizzuto, C. D., and J. G. Sodroski.</strong> <span class="cit-pub-date">1997</span>. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. <span class="cit-source">J. Virol.</span> <span class="cit-vol">71</span><strong>:</strong><span class="cit-fpage">4847</span>-4851.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=71/6/4847" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-71-1" title="View reference 71 in text" id="ref-71">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.71">
                           <div class="cit-metadata"><cite><strong>Sawai, E. T., M. S. Hamza, M. Ye, K. E. Shaw, and P. A. Luciw.</strong> <span class="cit-pub-date">2000</span>. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated
                                 Nef. <span class="cit-source">J. Virol.</span> <span class="cit-vol">74</span><strong>:</strong><span class="cit-fpage">2038</span>-2045.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=74/4/2038" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-72-1" title="View reference 72 in text" id="ref-72">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.72">
                           <div class="cit-metadata"><cite><strong>Schaeffer, E., R. Geleziunas, and W. C. Greene.</strong> <span class="cit-pub-date">2001</span>. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
                                 <span class="cit-source">J. Virol.</span> <span class="cit-vol">75</span><strong>:</strong><span class="cit-fpage">2993</span>-3000.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=75/6/2993" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-73-1" title="View reference 73 in text" id="ref-73">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.73">
                           <div class="cit-metadata"><cite><strong>Schiavoni, I., S. Trapp, A. C. Santarcangelo, V. Piacentini, K. Pugliese, A. Baur, and M. Federico.</strong> <span class="cit-pub-date">2004</span>. HIV-1 Nef enhances both membrane expression and virion incorporation of Env products. A model for the Nef-dependent increase
                                 of HIV-1 infectivity. <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">279</span><strong>:</strong><span class="cit-fpage">22996</span>-23006.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=279/22/22996" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-74-1" title="View reference 74 in text" id="ref-74">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.74">
                           <div class="cit-metadata"><cite><strong>Schindler, M., D. Rajan, A. Specht, C. Ritter, K. Pulkkinen, K. Saksela, and F. Kirchhoff.</strong> <span class="cit-pub-date">2007</span>. Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication
                                 and cytopathicity in ex vivo-infected human lymphoid tissue. <span class="cit-source">J. Virol.</span> <span class="cit-vol">81</span><strong>:</strong><span class="cit-fpage">13005</span>-13014.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=81/23/13005" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-75-1" title="View reference 75 in text" id="ref-75">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.75">
                           <div class="cit-metadata"><cite><strong>Schrager, J. A., V. Der Minassian, and J. W. Marsh.</strong> <span class="cit-pub-date">2002</span>. HIV Nef increases T cell ERK MAP kinase activity. <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">277</span><strong>:</strong><span class="cit-fpage">6137</span>-6142.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=277/8/6137" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-76-1" title="View reference 76 in text" id="ref-76">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.76">
                           <div class="cit-metadata"><cite><strong>Schwartz, O., V. Marechal, S. Le Gall, F. Lemonnier, and J. M. Heard.</strong> <span class="cit-pub-date">1996</span>. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. <span class="cit-source">Nat. Med.</span> <span class="cit-vol">2</span><strong>:</strong><span class="cit-fpage">338</span>-342.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1038/nm0396-338&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=8612235&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-77-1" title="View reference 77 in text" id="ref-77">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.77">
                           <div class="cit-metadata"><cite><strong>Schwartz, O., V. Marechal, O. Danos, and J. M. Heard.</strong> <span class="cit-pub-date">1995</span>. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. <span class="cit-source">J. Virol.</span> <span class="cit-vol">69</span><strong>:</strong><span class="cit-fpage">4053</span>-4059.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=69/7/4053" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-78-1" title="View reference 78 in text" id="ref-78">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.78">
                           <div class="cit-metadata"><cite><strong>Selig, L., J. C. Pages, V. Tanchou, S. Preveral, C. Berlioz-Torrent, L. X. Liu, L. Erdtmann, J. Darlix, R. Benarous, and S.
                                    Benichou.</strong> <span class="cit-pub-date">1999</span>. Interaction with the p6 domain of the Gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate
                                 lentiviruses. <span class="cit-source">J. Virol.</span> <span class="cit-vol">73</span><strong>:</strong><span class="cit-fpage">592</span>-600.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=73/1/592" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-79-1" title="View reference 79 in text" id="ref-79">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.79">
                           <div class="cit-metadata"><cite><strong>Sheehy, A. M., N. C. Gaddis, and M. H. Malim.</strong> <span class="cit-pub-date">2003</span>. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. <span class="cit-source">Nat. Med.</span> <span class="cit-vol">9</span><strong>:</strong><span class="cit-fpage">1404</span>-1407.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1038/nm945&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=14528300&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-80-1" title="View reference 80 in text" id="ref-80">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.80">
                           <div class="cit-metadata"><cite><strong>Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim.</strong> <span class="cit-pub-date">2002</span>. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. <span class="cit-source">Nature</span> <span class="cit-vol">418</span><strong>:</strong><span class="cit-fpage">646</span>-650.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1038/nature00939&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=12167863&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-81-1" title="View reference 81 in text" id="ref-81">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.81">
                           <div class="cit-metadata"><cite><strong>Simmons, A., V. Aluvihare, and A. McMichael.</strong> <span class="cit-pub-date">2001</span>. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators.
                                 <span class="cit-source">Immunity</span> <span class="cit-vol">14</span><strong>:</strong><span class="cit-fpage">763</span>-777.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/S1074-7613(01)00158-3&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=11420046&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-82-1" title="View reference 82 in text" id="ref-82">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.82">
                           <div class="cit-metadata"><cite><strong>Sol-Foulon, N., C. Esnault, Y. Percherancier, F. Porrot, P. Metais-Cunha, F. Bachelerie, and O. Schwartz.</strong> <span class="cit-pub-date">2004</span>. The effects of HIV-1 Nef on CD4 surface expression and viral infectivity in lymphoid cells are independent of rafts. <span class="cit-source">J. Biol. Chem.</span> <span class="cit-vol">279</span><strong>:</strong><span class="cit-fpage">31398</span>-31408.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jbc&amp;resid=279/30/31398" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-83-1" title="View reference 83 in text" id="ref-83">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.83">
                           <div class="cit-metadata"><cite><strong>Stove, V., I. Van de Walle, E. Naessens, E. Coene, C. Stove, J. Plum, and B. Verhasselt.</strong> <span class="cit-pub-date">2005</span>. Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8αβ. <span class="cit-source">J. Virol.</span> <span class="cit-vol">79</span><strong>:</strong><span class="cit-fpage">11422</span>-11433.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=79/17/11422" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-84-1" title="View reference 84 in text" id="ref-84">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.84">
                           <div class="cit-metadata"><cite><strong>Swigut, T., N. Shohdy, and J. Skowronski.</strong> <span class="cit-pub-date">2001</span>. Mechanism for down-regulation of CD28 by Nef. <span class="cit-source">EMBO J.</span> <span class="cit-vol">20</span><strong>:</strong><span class="cit-fpage">1593</span>-1604.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1093/emboj/20.7.1593&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=11285224&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-85-1" title="View reference 85 in text" id="ref-85">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.85">
                           <div class="cit-metadata"><cite><strong>Swingler, S., P. Gallay, D. Camaur, J. Song, A. Abo, and D. Trono.</strong> <span class="cit-pub-date">1997</span>. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. <span class="cit-source">J. Virol.</span> <span class="cit-vol">71</span><strong>:</strong><span class="cit-fpage">4372</span>-4377.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=71/6/4372" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-86-1" title="View reference 86 in text" id="ref-86">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.86">
                           <div class="cit-metadata"><cite><strong>Tobiume, M., J. E. Lineberger, C. A. Lundquist, M. D. Miller, and C. Aiken.</strong> <span class="cit-pub-date">2003</span>. Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. <span class="cit-source">J. Virol.</span> <span class="cit-vol">77</span><strong>:</strong><span class="cit-fpage">10645</span>-10650.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=77/19/10645" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-87-1" title="View reference 87 in text" id="ref-87">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.87">
                           <div class="cit-metadata"><cite><strong>Venzke, S., N. Michel, I. Allespach, O. T. Fackler, and O. T. Keppler.</strong> <span class="cit-pub-date">2006</span>. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target
                                 cells and thereby enhances resistance to superinfection. <span class="cit-source">J. Virol.</span> <span class="cit-vol">80</span><strong>:</strong><span class="cit-fpage">11141</span>-11152.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=80/22/11141" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-88-1" title="View reference 88 in text" id="ref-88">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.88">
                           <div class="cit-metadata"><cite><strong>Vodicka, M. A., D. M. Koepp, P. A. Silver, and M. Emerman.</strong> <span class="cit-pub-date">1998</span>. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. <span class="cit-source">Genes Dev.</span> <span class="cit-vol">12</span><strong>:</strong><span class="cit-fpage">175</span>-185.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=genesdev&amp;resid=12/2/175" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-89-1" title="View reference 89 in text" id="ref-89">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.89">
                           <div class="cit-metadata"><cite><strong>Welker, R., H. Hohenberg, U. Tessmer, C. Huckhagel, and H. G. Krausslich.</strong> <span class="cit-pub-date">2000</span>. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. <span class="cit-source">J. Virol.</span> <span class="cit-vol">74</span><strong>:</strong><span class="cit-fpage">1168</span>-1177.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=74/3/1168" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-90-1" title="View reference 90 in text" id="ref-90">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.90">
                           <div class="cit-metadata"><cite><strong>Welker, R., H. Kottler, H. R. Kalbitzer, and H. G. Krausslich.</strong> <span class="cit-pub-date">1996</span>. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral
                                 proteinase. <span class="cit-source">Virology</span> <span class="cit-vol">219</span><strong>:</strong><span class="cit-fpage">228</span>-236.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1006/viro.1996.0240&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=8623533&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-91-1" title="View reference 91 in text" id="ref-91">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.91">
                           <div class="cit-metadata"><cite><strong>Welker, R., M. Harris, B. Cardel, and H. G. Krausslich.</strong> <span class="cit-pub-date">1998</span>. Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis
                                 of its role in enhancement of viral infectivity. <span class="cit-source">J. Virol.</span> <span class="cit-vol">72</span><strong>:</strong><span class="cit-fpage">8833</span>-8840.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=72/11/8833" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-92-1" title="View reference 92 in text" id="ref-92">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.92">
                           <div class="cit-metadata"><cite><strong>Wolf, D., S. I. Giese, V. Witte, E. Krautkramer, S. Trapp, G. Sass, C. Haller, K. Blume, O. T. Fackler, and A. S. Baur.</strong> <span class="cit-pub-date">2008</span>. Novel (n) PKC kinases phosphorylate Nef for increased HIV transcription, replication and perinuclear targeting. <span class="cit-source">Virology</span> <span class="cit-vol">370</span><strong>:</strong><span class="cit-fpage">45</span>-54.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/j.virol.2007.08.015&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=17904606&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-93-1" title="View reference 93 in text" id="ref-93">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.93">
                           <div class="cit-metadata"><cite><strong>Wu, X., H. Liu, H. Xiao, J. Kim, P. Seshaiah, G. Natsoulis, J. D. Boeke, B. H. Hahn, and J. C. Kappes.</strong> <span class="cit-pub-date">1995</span>. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. <span class="cit-source">J. Virol.</span> <span class="cit-vol">69</span><strong>:</strong><span class="cit-fpage">3389</span>-3398.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=jvi&amp;resid=69/6/3389" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-94-1" title="View reference 94 in text" id="ref-94">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.94">
                           <div class="cit-metadata"><cite><strong>Yao, X. J., G. Kobinger, S. Dandache, N. Rougeau, and E. Cohen.</strong> <span class="cit-pub-date">1999</span>. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis
                                 of antiviral effect. <span class="cit-source">Gene Ther.</span> <span class="cit-vol">6</span><strong>:</strong><span class="cit-fpage">1590</span>-1599.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1038/sj.gt.3300988&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=10490769&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-95-1" title="View reference 95 in text" id="ref-95">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.95">
                           <div class="cit-metadata"><cite><strong>Zheng, Y. H., A. Plemenitas, C. J. Fielding, and B. M. Peterlin.</strong> <span class="cit-pub-date">2003</span>. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. <span class="cit-source">Proc. Natl. Acad. Sci. USA</span> <span class="cit-vol">100</span><strong>:</strong><span class="cit-fpage">8460</span>-8465.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=100/14/8460" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-96-1" title="View reference 96 in text" id="ref-96">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-83.2.1093.96">
                           <div class="cit-metadata"><cite><strong>Zheng, Y. H., A. Plemenitas, T. Linnemann, O. T. Fackler, and B. M. Peterlin.</strong> <span class="cit-pub-date">2001</span>. Nef increases infectivity of HIV via lipid rafts. <span class="cit-source">Curr. Biol.</span> <span class="cit-vol">11</span><strong>:</strong><span class="cit-fpage">875</span>-879.</cite></div>
                           <div class="cit-extra"><a href="http://jvi.asm.org/external-ref?access_num=10.1016/S0960-9822(01)00237-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jvi.asm.org/external-ref?access_num=11516650&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                  </ol>
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">American Society for Microbiology</li>
               </ul><span class="highwire-journal-article-marker-end"></span></div>
            <div class="social-bookmarking">
               
               <ul class="social-bookmark-links">
                  <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=CITEULIKE"><img src="citeulike.gif" alt="Add to CiteULike" title="CiteULike"></a><span class="soc-bm-link-text">CiteULike</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=DEL_ICIO_US"><img src="delicious.gif" alt="Add to Delicious" title="Delicious"></a><span class="soc-bm-link-text">Delicious</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-digg"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=DIGG"><img src="digg.gif" alt="Add to Digg" title="Digg"></a><span class="soc-bm-link-text">Digg</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-facebook"><a title="[opens in a new window]" target="_top" href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/short/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=FACEBOOK" class="sb-facebook" rel="external-nw"><img src="facebook.gif" alt="Add to Facebook" title="Facebook"></a><span class="soc-bm-link-text">Facebook</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-googleplus"><div id="___plusone_0" style="text-indent: 0px; margin: 0px; padding: 0px; background: none repeat ; 0% transparent; border-style: none; float: none; line-height: normal; font-size: 1px; vertical-align: baseline; display: inline-block; width: 24px; height: 15px;"><iframe title="+1" data-gapiattached="true" allowtransparency="true" src="1093_1.html" name="I0_1368280041304" id="I0_1368280041304" vspace="0" tabindex="0" style="position: static; top: 0px; width: 24px; margin: 0px; border-style: none; left: 0px; visibility: visible; height: 15px;" marginwidth="0" marginheight="0" hspace="0" frameborder="0" scrolling="no" width="100%"></iframe></div><a style="display: none;" href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="googleplus.jpg" alt="Add to Google+" title="Google+"></a><span class="soc-bm-link-text">Google+</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=MENDELEY"><img src="mendeley.gif" alt="Add to Mendeley" title="Mendeley"></a><span class="soc-bm-link-text">Mendeley</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-reddit"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=REDDIT"><img src="reddit.gif" alt="Add to Reddit" title="Reddit"></a><span class="soc-bm-link-text">Reddit</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-stumbleupon"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=STUMBLEUPON"><img src="stumbleupon.gif" alt="Add to StumbleUpon" title="StumbleUpon"></a><span class="soc-bm-link-text">StumbleUpon</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=TWITTER"><img src="twitter.gif" alt="Add to Twitter" title="Twitter"></a><span class="soc-bm-link-text">Twitter</span></li>
               </ul>
               
               <p class="social-bookmarking-help"><a href="http://jvi.asm.org/help/social_bookmarks.dtl">What's this?</a></p>
               
            </div><span id="related-urls"></span><div xmlns="http://www.w3.org/1999/xhtml" id="cited-by"><h2>Articles citing this article</h2><ul class="cited-by-list"><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Comparative Proteomic Analysis of HIV-1 Particles Reveals a Role for Ezrin and EHD4 in the Nef-Dependent Increase of Virus Infectivity </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">April 2013  </span><span class="cit-vol">87<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">7 </span><span class="cit-pages"><span class="cit-first-page">3729</span><span class="cit-sep">-</span><span class="cit-last-page">3740</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/87/7/3729" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/87/7/3729" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/87/7/3729" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Straightforward Selection of Broadly Neutralizing Single-Domain Antibodies Targeting the Conserved CD4 and Coreceptor Binding Sites of HIV-1 gp120 </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">January 2013  </span><span class="cit-vol">87<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">2 </span><span class="cit-pages"><span class="cit-first-page">1137</span><span class="cit-sep">-</span><span class="cit-last-page">1149</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/87/2/1137" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/87/2/1137" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/87/2/1137" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Suboptimal Provirus Expression Explains Apparent Nonrandom Cell Coinfection with HIV-1 </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">August 2012  </span><span class="cit-vol">86<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">16 </span><span class="cit-pages"><span class="cit-first-page">8810</span><span class="cit-sep">-</span><span class="cit-last-page">8820</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/86/16/8810" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/86/16/8810" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/86/16/8810" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Single-Domain Antibody-SH3 Fusions for Efficient Neutralization of HIV-1 Nef Functions </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">May 2012  </span><span class="cit-vol">86<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">9 </span><span class="cit-pages"><span class="cit-first-page">4856</span><span class="cit-sep">-</span><span class="cit-last-page">4867</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/86/9/4856" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/86/9/4856" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/86/9/4856" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Recruitment of the Nuclear Form of Uracil DNA Glycosylase into Virus Particles Participates in the Full Infectivity of HIV-1 </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">March 2012  </span><span class="cit-vol">86<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">5 </span><span class="cit-pages"><span class="cit-first-page">2533</span><span class="cit-sep">-</span><span class="cit-last-page">2544</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/86/5/2533" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/86/5/2533" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/86/5/2533" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody </span> <cite><abbr title="Blood" class="site-title">Blood</abbr> <span class="cit-print-date">March 2011  </span><span class="cit-vol">117<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">13 </span><span class="cit-pages"><span class="cit-first-page">3559</span><span class="cit-sep">-</span><span class="cit-last-page">3568</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://bloodjournal.hematologylibrary.org/cgi/content/abstract/117/13/3559" rel="abstract">Abstract</a></li><li><a href="http://bloodjournal.hematologylibrary.org/cgi/content/full/117/13/3559" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://bloodjournal.hematologylibrary.org/cgi/reprint/117/13/3559" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">HIV-1 Nef Triggers Macrophage Fusion in a p61Hck- and Protease-Dependent Manner </span> <cite><abbr title="The Journal of Immunology" class="site-title">J. Immunol.</abbr> <span class="cit-print-date">June 2010  </span><span class="cit-vol">184<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">12 </span><span class="cit-pages"><span class="cit-first-page">7030</span><span class="cit-sep">-</span><span class="cit-last-page">7039</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://www.jimmunol.org/cgi/content/abstract/184/12/7030" rel="abstract">Abstract</a></li><li><a href="http://www.jimmunol.org/cgi/content/full/184/12/7030" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://www.jimmunol.org/cgi/reprint/184/12/7030" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments </span> <cite><abbr title="Blood" class="site-title">Blood</abbr> <span class="cit-print-date">May 2010  </span><span class="cit-vol">115<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">21 </span><span class="cit-pages"><span class="cit-first-page">4226</span><span class="cit-sep">-</span><span class="cit-last-page">4236</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://bloodjournal.hematologylibrary.org/cgi/content/abstract/115/21/4226" rel="abstract">Abstract</a></li><li><a href="http://bloodjournal.hematologylibrary.org/cgi/content/full/115/21/4226" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://bloodjournal.hematologylibrary.org/cgi/reprint/115/21/4226" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1 </span> <cite><abbr title="PNAS" class="site-title">Proc. Natl. Acad. Sci. USA</abbr> <span class="cit-print-date">May 2010  </span><span class="cit-vol">107<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">20 </span><span class="cit-pages"><span class="cit-first-page">9364</span><span class="cit-sep">-</span><span class="cit-last-page">9369</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://www.pnas.org/cgi/content/abstract/107/20/9364" rel="abstract">Abstract</a></li><li><a href="http://www.pnas.org/cgi/content/full/107/20/9364" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://www.pnas.org/cgi/reprint/107/20/9364" rel="full-text.pdf">PDF</a></li></ul>  </div> </li></ul></div></div>
         <div style="height: 20976px;" id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="http://jvi.asm.org/content/83/2/1083.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="http://jvi.asm.org/content/83/2/1105.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="http://jvi.asm.org/content/83/2.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              
                              		<span class="slug-metadata-note ahead-of-print">

                                 
                                 Published ahead of print
                                 
                                 <span class="slug-ahead-of-print-date">5 November 2008</span>,
                                 doi:
                                 <span class="slug-doi">10.1128/​JVI.01633-08
                                    </span>
                                 </span>
                              
                              <cite>
                                 	    <abbr title="Journal of Virology" class="slug-jnl-abbrev">

                                    J. Virol.</abbr><span class="slug-pub-date" itemprop="datePublished">

                                    	    January 2009 
                                    </span>
                                 	    <span class="slug-vol">

                                    vol. 83 
                                    </span><span class="slug-issue">

                                    no. 2 
                                    </span><span class="slug-pages">

                                    1093-1104
                                    </span>
                                 </cite>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="http://jvi.asm.org/content/83/2/1093.abstract" rel="view-abstract">Abstract</a><span class="viewspecificaccesscheck jvi;83/2/1093 abstract"></span></li>
                        <li><a href="http://jvi.asm.org/content/83/2/1093.figures-only" rel="view-figures-only">Figures</a><span class="viewspecificaccesscheck jvi;83/2/1093 figsonly"></span></li>
                        <li class="notice full-text-view-link primary"><span class="variant-indicator">» <span>Full Text</span></span><span class="viewspecificaccesscheck jvi;83/2/1093 full"></span></li>
                        <li class="notice full-text-pdf-view-link primary"><a href="http://jvi.asm.org/content/83/2/1093.full.pdf+html" rel="view-full-text.pdf">PDF</a><span class="viewspecificaccesscheck jvi;83/2/1093 reprint"></span></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Classifications</span></a></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search" href="http://jvi.asm.org/search?tocsectionid=VIRUS-CELL+INTERACTIONS&amp;sortspec=date&amp;submit=Submit">VIRUS-CELL INTERACTIONS</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Services</span></a></h4>
                     <ol>
                        <li class="mail-a-friend-link icon-link"><a href="http://jvi.asm.org/email?gca=jvi;83/2/1093&amp;current-view-path=/content/83/2/1093.full">

                              Email this article to a colleague</a></li>
                        <li class="red"><a href="http://jvi.asm.org/search?qbe=jvi;JVI.01633-08&amp;journalcode=all&amp;citation=Laguette%20et%20al.%2083%20%282%29:%201093&amp;submit=yes">Similar articles in ASM journals</a></li>
                        <li class="alert-link icon-link"><a href="http://jvi.asm.org/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jvi;83/2/1093&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jvi.asm.org/content/83/2/1093.full">Alert me when this article is cited</a></li>
                        <li class="alert-link icon-link"><a href="http://jvi.asm.org/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=83/2/1093&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jvi.asm.org/content/83/2/1093.full">Alert me if a correction is posted</a></li>
                        <li class="similar-link"><a href="http://jvi.asm.org/search?qbe=jvi;JVI.01633-08&amp;citation=Laguette%20et%20al.%2083%20%282%29:%201093&amp;submit=yes">Similar articles in this journal</a></li>
                        <li class="similar-link nodata"><div id="cb-loaded-isi-related-none">No Web of Science related articles</div></li>
                        <li class="similar-link"><a href="http://jvi.asm.org/external-ref?access_num=18987145&amp;link_type=MED_NBRS" class="similar-link">Similar articles in PubMed</a></li>
                        <li><a href="http://jvi.asm.org/cgi/alerts/etoc">Alert me to new issues of 
                              <em xmlns="">JVI</em>
                              </a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="http://jvi.asm.org/citmgr?gca=jvi;83/2/1093">Download to citation manager</a></li>
                        <li class="copyright-link icon-link"><a class="request-permissions" href="https://s100.copyright.com/AppDispatchServlet?publisherName=asm&amp;publication=jvi&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity&amp;publicationDate=January%2015,%202009&amp;author=Nadine%20Laguette,%20Serge%20Benichou,%20St%C3%A9phane%20Basmaciogullari%20et%20al.&amp;startPage=1093&amp;contentID=10.1128/JVI.01633-08&amp;orderBeanReset=true&amp;endPage=1104&amp;volumeNum=83&amp;issueNum=2&amp;copyright=American%20Society%20for%20Microbiology" target="_top">Reprints and Permissions</a></li>
                        <li><a href="http://jvi.asm.org/site/misc/terms.xhtml">

                              Copyright Information 
                              </a></li>
                        <li><a href="http://www.asmpress.org/" target="_top">

                              Books from ASM Press 
                              </a></li>
                        <li><a href="http://www.microbeworld.org/" target="_top">

                              MicrobeWorld 
                              </a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-cit">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Citing Articles</span></a></h4>
                     <ol style="display: none;">
                        <li class="hw-citing-link"><a href="#cited-by">View citing article information</a></li>
                        <li><a xmlns="http://www.w3.org/1999/xhtml" href="http://jvi.asm.org/external-ref?access_num=jvi;83/2/1093&amp;link_type=ISI_CITING&amp;external_url=http%3A%2F%2Fgateway.webofknowledge.com%2Fgateway%2FGateway.cgi%3FGWVersion%3D2%26SrcApp%3DPARTNER_APP%26SrcAuth%3Dstanwire%26KeyUT%3D000262045000055%26DestLinkType%3DCitingArticles%26DestApp%3DWOS_CPL%26UsrCustomerID%3D269fc60adb004b0b719031a97aedf5e9">Citing articles via Web of Science (21)</a></li>
                        <li><a href="http://jvi.asm.org/external-ref?access_num=http://jvi.asm.org/content/83/2/1093.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Google Scholar</span></a></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ALaguette%20author%3AN.%22" class="cb-art-gs-auth author-link">Articles by  Laguette, N.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ABasmaciogullari%20author%3AS.%22" class="cb-art-gs-auth author-link">Articles by  Basmaciogullari, S.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="http://jvi.asm.org/external-ref?access_num=http://jvi.asm.org/content/83/2/1093.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>PubMed</span></a></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="http://jvi.asm.org/external-ref?access_num=18987145&amp;link_type=PUBMED" class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://jvi.asm.org/external-ref?access_num=Laguette%20N&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Laguette, N.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://jvi.asm.org/external-ref?access_num=Basmaciogullari%20S&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Basmaciogullari, S.</a></li>
                        <li>
                           <ul xmlns="http://www.w3.org/1999/xhtml">
   <li>Pubmed/NCBI databases
      <ul>
         <li><a href="http://jvi.asm.org/cgi/external_ref?id=pubmed_gene&amp;type=acheck&amp;target=gene&amp;pmid=18987145&amp;link_type=ENTREZLINKS">Gene</a></li>
         <li><a href="http://jvi.asm.org/cgi/external_ref?id=pubmed_homologene&amp;type=acheck&amp;target=homologene&amp;pmid=18987145&amp;link_type=ENTREZLINKS">HomoloGene</a></li>
         <li><a href="http://jvi.asm.org/cgi/external_ref?id=pubmed_protein&amp;type=acheck&amp;target=protein&amp;pmid=18987145&amp;link_type=ENTREZLINKS">Protein</a></li>
         <li><a href="http://jvi.asm.org/cgi/external_ref?id=pubmed_unigene&amp;type=acheck&amp;target=unigene&amp;pmid=18987145&amp;link_type=ENTREZLINKS">UniGene</a></li>
      </ul>
   </li>
</ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed nodata" id="cb-art-rel">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Related Content</span></a></h4>
                     <ol style="display: none;">
                        <li class="nodata"><div id="cb-loaded-related-urls-none">No related web pages</div></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed soc-links icon-link collapsed" id="cb-art-soc">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Social Bookmarking</span></a></h4>
                     <ol style="display: none;">
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=CITEULIKE"><img src="citeulike.gif" alt="Add to CiteULike" title="CiteULike"></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=DEL_ICIO_US"><img src="delicious.gif" alt="Add to Delicious" title="Delicious"></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-digg"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=DIGG"><img src="digg.gif" alt="Add to Digg" title="Digg"></a><span class="soc-bm-link-text">Digg</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a title="[opens in a new window]" target="_top" href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/short/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=FACEBOOK" class="sb-facebook" rel="external-nw"><img src="facebook.gif" alt="Add to Facebook" title="Facebook"></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><div id="___plusone_1" style="text-indent: 0px; margin: 0px; padding: 0px; background: none repeat ; 0% transparent; border-style: none; float: none; line-height: normal; font-size: 1px; vertical-align: baseline; display: inline-block; width: 24px; height: 15px;"><iframe title="+1" data-gapiattached="true" allowtransparency="true" src="1093_2.html" name="I1_1368280041614" id="I1_1368280041614" vspace="0" tabindex="0" style="position: static; top: 0px; width: 24px; margin: 0px; border-style: none; left: 0px; visibility: visible; height: 15px;" marginwidth="0" marginheight="0" hspace="0" frameborder="0" scrolling="no" width="100%"></iframe></div><a style="display: none;" href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="googleplus.jpg" alt="Add to Google+" title="Google+"></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=MENDELEY"><img src="mendeley.gif" alt="Add to Mendeley" title="Mendeley"></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-reddit"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=REDDIT"><img src="reddit.gif" alt="Add to Reddit" title="Reddit"></a><span class="soc-bm-link-text">Reddit</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-stumbleupon"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=STUMBLEUPON"><img src="stumbleupon.gif" alt="Add to StumbleUpon" title="StumbleUpon"></a><span class="soc-bm-link-text">StumbleUpon</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="http://jvi.asm.org/external-ref?tag_url=http://jvi.asm.org/cgi/content/long/83/2/1093&amp;title=Human%20Immunodeficiency%20Virus%20Type%201%20Nef%20Incorporation%20into%20Virions%20Does%20Not%20Increase%20Infectivity+--+Laguette%20et%20al.%2083%20%282%29%3A%201093+--+&amp;doi=10.1128/JVI.01633-08&amp;link_type=TWITTER"><img src="twitter.gif" alt="Add to Twitter" title="Twitter"></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="http://jvi.asm.org/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">ABSTRACT</a></li>
                        <li><a href="#sec-1">MATERIALS AND METHODS</a></li>
                        <li><a href="#sec-10">RESULTS</a></li>
                        <li><a href="#sec-16">DISCUSSION</a></li>
                        <li><a href="#ack-1">ACKNOWLEDGMENTS</a></li>
                        <li><a href="#fn-group-1">FOOTNOTES</a></li>
                        <li><a href="#ref-list-1">REFERENCES</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div style="height: 20976px;" id="col-3">
            
            <div class="content-box" id="sidebar-current-issue">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>current issue</span></h3>
                  <div class="cb-section">
                     <ol><span><a href="http://jvi.asm.org/content/current" rel="current-issue">June 2013, volume 87, issue 11</a></span></ol>
                  </div>
                  <div class="cb-section">
                     <ol>
                        <li>
                           <div class="current-issue"><a href="http://jvi.asm.org/content/current" rel="current-issue"><img src="11.cover.gif" alt="Current Issue" height="89" width="67"></a></div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-opened" id="sidebar-cur-issue-coverlines">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Spotlights in the Current Issue</span></a></h4>
                     <ul>
                        <li><a href="http://jvi.asm.org/content/87/11/6061">Anti-Self Cellular Immunity Functions in HIV Pathogenesis</a></li>
                        <li><a href="http://jvi.asm.org/content/87/11/6061">Nucleocytoplasmic Transport of Polyadenylated mRNAs Is Blocked by Rotavirus</a></li>
                        <li><a href="http://jvi.asm.org/content/87/11/6061">Merkel Cell Polyomavirus Large T Antigen Has Growth-Promoting and Inhibitory Activities</a></li>
                        <li><a href="http://jvi.asm.org/content/87/11/6061">A Novel Nuclear Function for a Tobamovirus Movement Protein</a></li>
                        <li><a href="http://jvi.asm.org/content/87/11/6061">Ribavirin Exerts Mutagenic Effects on Hepatitis C Virus</a></li>
                     </ul>
                  </div>
                  <div class="cb-section sidebar-etoc-link">
                     <ol>
                        <li><a href="http://jvi.asm.org/cgi/alerts/etoc">Alert me to new issues of 
                              <em xmlns="">JVI</em>
                              </a></li>
                     </ol>
                  </div>
               </div>
            </div>
            <div id="sidebar-global-nav">
               
               
               <ul class="button-list pub-links">
                  <li class="first"><a href="http://jvi.asm.org/site/misc/about.xhtml" title="About "><span>About 
                           <em xmlns="">JVI</em>
                           </span></a></li>
                  <li><a target="_top" href="http://journals.asm.org/subscriptions/" rel="external-nw" title="Subscribers [opens in a new window]"><span>Subscribers</span></a></li>
                  <li><a href="http://jvi.asm.org/site/misc/authors.xhtml" title="Authors"><span>Authors</span></a></li>
                  <li><a href="http://jvi.asm.org/site/misc/reviewers.xhtml" title="Reviewers"><span>Reviewers</span></a></li>
                  <li><a target="_top" href="http://journals.asm.org/site/misc/addir.xhtml" rel="external-nw" title="Advertisers [opens in a new window]"><span>Advertisers</span></a></li>
                  <li><a target="_top" href="http://www.asm.org/index.php/news-room/whats-new-in-media-information.html" rel="external-nw" title="Inquiries from the Press [opens in a new window]"><span>Inquiries from the Press</span></a></li>
                  <li><a href="http://journals.asm.org/site/misc/reprints.xhtml" title="Permissions &amp; Commercial Reprints"><span>Permissions &amp; Commercial Reprints</span></a></li>
                  <li><a href="http://journals.asm.org/site/misc/index_compliance.xhtml" title="ASM Journals Public Access Policy"><span>ASM Journals Public Access Policy</span></a></li>
                  <li class="last"><a href="http://jvi.asm.org/rss" title="
               "><span>
                           
                           <em xmlns="">JVI</em> RSS Feeds</span>
                        
                        <img alt="
                JVI  RSS Feeds" src="icon_rss_tiny.gif"></a>
                     
                     
                     
                  </li>
               </ul>
               	
               <div class="sidebar-icon-group">
                  
                  <a href="http://jvi.msubmit.net/cgi-bin/main.plex">
                     <img src="button_submit.gif" class="submit-icon" title="submit">
                     </a>
                  
               </div>
               
            </div>
            <div class="asm-icon">
               <a title="[opens in a new window]" target="_top" href="http://journals.asm.org/" rel="external-nw" class="img"><img src="society_logo.gif" class="publisher-icon" title="Society Logo"></a>
               <a title="[opens in a new window]" target="_top" href="http://highwire.stanford.edu/" rel="external-nw" class="img"><img src="hplogo.gif" class="pub-icon" title="HighWire Press Logo"></a>						
               
            </div>
            
            
            
         </div>
         <div id="footer">
            
            <div class="bar">
               	      
               <div class="footer-group footer-col-left">
                  	        
                  <div class="asmjnls">
                     
                     <div class="asmjnls-logo"><a href="http://journals.asm.org/"><img src="asmlogo_footer_clear_s.gif" alt="Journals.ASM.org" border="0" height="40" width="129"></a></div>
                     
                     <div class="asmjnls-location">
                        
                        <p class="addr">1752 N Street N.W. • Washington DC 20036</p>
                        
                        <p class="phone">202.737.3600 • 202.942.9355 fax • journals@asmusa.org</p>
                        
                     </div>   
                     
                  </div>
                  	      
               </div>
               	
               <div class="footer-group footer-col-right">
                  	  
                  <ul class="issns">
                     <li>
                        <span>Print ISSN: </span>
                        <span class="issn">0022-538X</span>
                        
                     </li>
                     <li>
                        <span>Online ISSN: </span>
                        <span class="issn">1098-5514</span>
                        
                     </li>
                  </ul>
                  	
               </div>
               
            </div>
            
            <div class="footer-copyright">
               
               <div class="asmjnls-copy">
                  
                  <p class="copyw">
                     <a href="http://journals.asm.org/site/misc/terms.xhtml">
                        <span class="linkb">Copyright © 2013 </span></a> 
                     by the <a href="http://www.asm.org/">
                        <span class="linkb">American Society for Microbiology.&nbsp;&nbsp;</span>
                        </a>
                     For an alternate route to <span class="lowerasm">JVI</span>.asm.org, visit: 
                     <a href="http://intl-jvi.asm.org/">http://intl-<span class="lowerasm">JVI</span>.asm.org</a>&nbsp;&nbsp;|&nbsp; &nbsp; 
                     <a href="http://jvi.asm.org/help/using/alternate-route">More Info»</a>
                     
                  </p>
                  
               </div>
               
            </div>
            
            
            <div class="block-2 sb-div"></div>
            
         </div><script type="text/javascript">

        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script src="ga.js" type="text/javascript"></script><script type="text/javascript">

        try {
        var pageTracker = _gat._getTracker("UA-5821458-1");
        pageTracker._trackPageview();
        } catch(err) {}
        </script><script type="text/javascript">

        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script src="ga.js" type="text/javascript"></script><script type="text/javascript">

        try {
        var pageTracker = _gat._getTracker("UA-189672-34");
        pageTracker._setDomainName(".asm.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   
<div id="fancybox-tmp"></div><div id="fancybox-loading"><div></div></div><div id="fancybox-overlay"></div><div id="fancybox-wrap"><div id="fancybox-outer"><div class="fancybox-bg" id="fancybox-bg-n"></div><div class="fancybox-bg" id="fancybox-bg-ne"></div><div class="fancybox-bg" id="fancybox-bg-e"></div><div class="fancybox-bg" id="fancybox-bg-se"></div><div class="fancybox-bg" id="fancybox-bg-s"></div><div class="fancybox-bg" id="fancybox-bg-sw"></div><div class="fancybox-bg" id="fancybox-bg-w"></div><div class="fancybox-bg" id="fancybox-bg-nw"></div><div id="fancybox-content"></div><a id="fancybox-close"></a><div id="fancybox-title"></div><a href="javascript:;" id="fancybox-left"><span class="fancy-ico" id="fancybox-left-ico"></span></a><a href="javascript:;" id="fancybox-right"><span class="fancy-ico" id="fancybox-right-ico"></span></a></div></div></body>
</html>
